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Introduction 
 
P-type ATPases are membrane proteins typically involved in ion transport. Even though the 
two best known members of this protein family, Ca2+-ATPase and Na+/K+-ATPase, have 
been studied for decades, the functional mechanism has not been described in detail. 
Recently, there has been significant progress in the field, as the crystal structure of Ca2+-
ATPase has been determined in two different states (Toyoshima et al., 2000; Toyoshima & 
Nomura, 2002). 
 
According to the basic scheme (De Meis & Vianna, 1979) the transport cycle consists of 
four main steps. In the first step cations bind to the ATPase from the cytoplasmic side, 
activating the protein. The ATPase phosphorylates itself by ATP, creating an E1~P species. 
This high-energy form converts rapidly to the E2-P state. Cation transport is linked to this 
step. In the third phase, the enzyme is dephosphorylated after which it returns to the E1 
state in the last step. The key question is how the phosphorylation/dephosphorylation 
reactions in the catalytic binding site drive the translocation of cations bound to a site 
located some 50 Å from the former (Toyoshima et al., 2000).  
 
Recent studies have concentrated on the ATP binding site. ATP not only acts as a substrate 
in the phosphorylation reaction, but the energy of ATP binding is also used to drive the E2-
E1 state conversion. While the orientation of the nucleotide bound  to Ca2+- and Na+/K+-
ATPase is emerging, it is interesting that none of the ATP-binding residues are conserved 
in heavy-metal-transporting P-type ATPases, known as P1B-ATPases.  
 
Heavy metals, such as copper and zinc, are vital elements in metalloenzymes, but they are 
also potentially toxic, if existing in too high concentrations. Hence, an elaborate machinery 
has been evolved to transport heavy metals both into and out of the cytoplasm. P1B-
ATPases are mainly used to export heavy metals in prokaryotes, but in eukaryotes they are 
also involved in intracellular metal transport, playing a role in metalloprotein biogenesis.  
 
Humans have two P1B-ATPases, which function in copper homeostasis. Mutations in their 
genes bring about copper disorders called Wilson and Menkes diseases. Menkes disease is 
a copper deprivation state caused usually by large deletions in a gene of the copper ATPase 
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responsible for copper delivery to the circulation. In contrast, Wilson disease is a copper 
accumulation disorder which is caused by a blocked copper excretion route via bile. Most 
of the mutations causing Wilson disease are point mutations and they are likely to preserve 
partial activity. 
 
P1B-ATPases possess several characteristic features which distinguish them from other P-
type ATPases. They lack all the residues forming the ATP-binding site in Ca2+- and 
Na+/K+-ATPases, but instead they have two sequence motifs in their N domain; an HP 
dipeptide and a GxGxxG/A motif. Mutation of the histidine to glutamine in the first motif 
is the most common Wilson disease mutation in the Western population. 
In addition to these motifs, two metal-binding sites are found. An N-terminal CxxC motif is 
the site where the transported metal ion is first delivered by copper chaperones. The second 
site is a CPx motif found in the putative sixth TM-helix. This is likely to form the actual 
translocation site. The motif exists in several variants, the most common of them being 
CPC. However, the same motif is found both in copper and zinc-translocating ATPases, 
indicating that the variation of this motif alone does not determine the metal selectivity. 
 
The primary focus of this work is to characterize nucleotide and metal-binding sites in P1B-
ATPases. The main strategy is to introduce Wilson disease mutation analogs into a 
bacterial zinc-translocating P-type ATPase, ZntA. The mutagenesis was extended to cover 
the metal-binding motifs CxxC and CPC. In addition, molecular modeling of the ZntA N 
domain was carried out. The model is based on the crystal structures sarcoplasmic of Ca2+-
ATPase.   
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Review of the literature 
1 P-type ATPases 
1.1 General aspects of P-type ATPases 
 
Biological membranes separate subcellular compartments and entire cells from their 
surroundings. Basically they are composed of a lipid bilayer, which acts as a barrier that 
prevents uncontrolled passage of water soluble molecules, and of proteins that transport 
various solutes in an organized way. Molecular transport across a membrane occurs either 
passively down to the concentration gradient, or actively by using the energy of ion 
gradients or ATP hydrolysis. P-type ATPases form a large family of transporters utilizing 
the latter strategy. They are distinct from all the other ATPases in that they are transiently 
phosphorylated during the catalytic cycle. 
 
Canonical P-type ATPases: Ca2+-ATPase and Na+/K+-ATPase 
The two best known P-type ATPases, Na+/K+-ATPase and sarcoplasmic Ca2+-ATPase were 
first reported in 1957 and 1961, respectively, and they remain the best characterized 
members of the P-type ATPase protein family (Skou, 1957; Hasselbach & Makinose, 
1961). Sarcoplasmic Ca2+-ATPase is responsible for keeping the concentration of 
cytoplasmic Ca2+ ions at a low level. Ca2+ is a well-known secondary messenger that, when 
released from the sarcoplasmic reticulum, triggers a muscle contraction. To allow the 
muscle to relax again, the ATPase pumps the Ca2+ ions back to the sarcoplasmic reticulum 
(for more information on the specific Ca2+-ATPase types and their functions, see Shull et 
al., 2003).   
Na+/K+-ATPase exchanges three cytoplasmic Na+ ions for two extracellular K+ ions 
(recently reviewed in Kaplan, 2002). The accumulation of positive charge on the 
extracellular side brings about an electric potential across the membrane. This potential 
energy is used by all animal cells by coupling the backflow of Na+ ions to the uptake of a 
variety of solutes. Na+/K+-ATPase spends more than 25% of the cellular ATP to maintain 
the electrochemical gradient of Na+ and K+. This potential plays a special role in nerve 
cells, which transmit nerve signals. The signals are created by transient depolarization, i.e. 
disappearance of the membrane potential. This occurs when Na+ and K+ channels open 
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allowing these cations to flow down their concentration gradient. To be able to transmit a 
signal again, the membrane potential must be recreated by Na+/K+-ATPase.   
 
1.2 Subfamilies of P-type ATPases  
 
Na+/K+- and Ca2+-ATPases have been studied for decades and the whole family of P-type 
ATPases was first known as transporters of bulk solutes like Na+, K+, Ca2+ and H+. During 
the last ten years, the functional field of P-type ATPases has broadened significantly and 
now includes also activities such as heavy metal detoxification and flipping of lipid 
molecules from outer to inner leaflet of a bilayer. 
Phylogenetic analysis reveals five main branches in the P-type ATPase family (Axelsen & 
Palmgren, 1998; Palmgren & Axelsen, 1998) (see Figure 1). The first group, the P1-
ATPases, contain heavy metal transporting ATPases, denoted P1B-ATPases, and a unique 
K+-ATPase, Kdp, that forms its own sub-group of P1A-ATPases. In literature heavy metal-
transporting P-type ATPases have also been called soft-metal ATPases, P1-type ATPases 
and CPx-ATPases. Ca2+- and Na+/K+-ATPases both belong to P2-ATPases, although in 
different sub-branches of P2A- and P2C-ATPases respectively. H+-ATPases are classified as 
P3-ATPases. P4-ATPases are not involved in cation transport, but experimental evidence 
indicates them to be lipid flippases (Auland et al., 1994; Tang et al., 1996). Finally, there is 
the last main branch of P5-ATPases, the function of which remains to be identified.  
Notably, the phylogenetic tree is organized into subfamilies according to the substrates of 
ATPases regardless of whether they originate from eukaryotes or prokaryotes.  
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Figure 1. The phylogenetic tree of P-type ATPases. Substrate specificity of ATPases is 
listed for the most common ATPase sub-groups. PM and SR denote for plasmamembrane 
and sarcoplasmic forms of the Ca2+-ATPases respectively. The figure is a simplified 
modification from Palmgren & Axelsen, 1998. 
 
 
2 Catalytic cycle of P-type ATPases 
2.1 The E1-E2 model of the catalytic cycle 
 
Allosteric model of two conformational states 
Early studies conducted on Na+/K+- and Ca2+-ATPases form the basis of the classical model 
of the catalytic cycle (Post et al., 1965; Post et al., 1972; Makinose, 1971; Makinose & 
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Hasselbach, 1971; Shigekawa & Dougherty, 1978). The key findings that led to the 
formulation of the functional model were that the enzyme can exist in two principal states, 
one of which can be phosphorylated by ATP (Post et al., 1965; Martonosi, 1967; 
Yamamoto & Tonomura, 1967; Yamamoto & Tonomura, 1968; Makinose, 1969), and the 
other which reacts with inorganic phosphate (Pi) (Masuda & de Meis, 1973; Glynn & 
Karlish 1975; Robinson & Flashner, 1979). Later these states were realized to represent 
intermediates of the catalytic cycle.  
 
 
Figure 2. The classical model of the catalytic cycle of Ca2+-ATPase. Ca2+ ions are 
represented as grey balls. In E1 state the cation-binding sites face the cytoplasm, whereas in 
the E2 state they are open to the lumenal side of the membrane. This side has a higher 
concentration of Ca2+, but these cations do not bind to the ATPase because of the low-
affinity of the metal-binding sites in the E2 state. In the E1-P state the cations are occluded 
and have no access to either side of the membrane. Ca2+-ATPase transports two ions per 
cycle, but the stoichiometry depends on the specific type of the ATPase. Na+/K+-ATPase, 
for instance, transports three Na+ ions outside a cell. In addition, the final step of E2 → E1 
state conversion is also connected to a transport event in some P-type ATPases. Two K+ 
ions are imported by Na+/K+-ATPase, whereas sarcoplasmic Ca2+-ATPase is likely to 
transport two H+.  
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Long before any actual evidence of structural changes occurring during the catalytic cycle, 
a transport model of two alternating conformational states was formulated (Jardetzky, 
1966). Initial findings supporting this idea included the protease cleavage studies, which 
displayed a different pattern of Na+/K+-ATPase fragments depending on whether the 
experiment was carried out in the presence of Na+ or K+ salt (Jørgensen, 1975; Jørgensen, 
1977). A lot of evidence has been accumulated to support these results, but the final proof 
was gained only a few years ago from the crystal structures of the Ca2+-ATPase in the E1 
and E2 states (Toyoshima et al., 2000; Toyoshima & Nomura, 2002). 
As Ca2+-ATPase is the best characterized P-type ATPase up to date, it is used as an 
representative example for a P-type ATPase in the following discussion. The foundation of 
this model is the assumption that the enzyme can adopt two principal conformational states, 
which are called E1 and E2. The ATPase in the E1 state has a high affinity for Ca2+ and the 
Ca2+ binding sites are accessible only from the cytoplasmic side. In contrast, an enzyme in 
the E2 state has a low affinity for Ca2+ and in this conformation, the binding sites face the 
opposite side of the membrane. The principles of the catalytic cycle can be illustrated by a 
minimal functional model consisting of four steps (Albers, 1967; Post et al., 1972; 
Makinose, 1973; de Meis & Vianna, 1979) (Figure 2). 
 
Catalytic cycle – the sequence of events 
The cycle begins with the binding of the cytoplasmic cations to their binding sites with the 
enzyme being in the E1 state. The ATP binding site must be occupied also for the reaction 
to start. However, unlike the substrate cations, ATP can bind during almost any phase of 
the catalytic cycle (Kanazawa et al., 1971; Skou, 1979), and therefore metal binding can be 
considered as the critical event that triggers ATPase activity.  
In the first step of the cycle, the activated enzyme transfers the γ-phosphate of ATP to a 
certain aspartate in the catalytic site. This results in occlusion of the cations in their binding 
site, meaning that they become trapped inside the enzyme with no access to either side of 
the membrane. The state formed by the autophosphorylation, E1~P, is unstable and converts 
rapidly to the E2-P state. This is the second step of the cycle, opening up the cation binding 
sites to the other side of the membrane (Makinose, 1973; Ikemoto, 1975; Ikemoto, 1976). 
Because at the E2/E2-P state these sites have a low affinity, the cations are released to the 
lumenal/extracellular side of the membrane. The dephosphorylation of the enzyme, which 
follows the vacating of the cation binding sites, makes up the third step of the catalytic 
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cycle. The final step is the conformational change that returns the enzyme back to the E1 
state. 
 
2.2 Energetics and stoichiometry of the cycle  
 
E1~P and E2-P phosphoenzyme species 
The catalytic cycle of P-type ATPases is reversible. In nature these pumps use the chemical 
energy stored in the form of ATP to create ion gradients across a membrane, but in vitro 
they can be used to synthesize ATP from ADP and Pi by utilizing the potential energy of 
the artificially made ion gradient (Makinose, 1971; Makinose & Hasselbach, 1971).  
In the presence of substrate cations the enzyme is mainly in the E1 state. Instead, in the 
absence of cations the enzyme prefers the E2 conformation (Skou & Esmann, 1983). In this 
state, an ATPase can be phosphorylated by Pi to form the E2-P state (Carvalho et al., 1976; 
Masuda & de Meis, 1973; Glynn & Karlish, 1975; Robinson & Flashner, 1979). This 
phosphoenzyme species is in a low-energy state. In contrast, the phosphoenzyme formed by 
ATP, the E1~P state, is a high-energy form. The energy level of the phosphointermediates is 
reflected in their ability to donate the phosphoryl group: the E1~P form is able to 
phosphorylate ADP back to ATP, whereas the E2-P is not dephosphorylated by ADP 
(Martonosi, 1967; Shigekawa & Dougherty, 1978). Hence, the two phosphoenzyme species 
are called ADP sensitive and ADP insensitive forms, respectively.  
Characterization of the phosphorylation and dephosphorylation properties of mutant 
proteins gives detailed information about the specific effect the mutations have during a 
particular step of the catalytic cycle. 
 
E2 → E1 state transition  
Na+/K+-ATPase pumps three Na+ ions out of a cell during the E1 → E2 state conversion. In 
addition the last step of the catalytic cycle, the E2 → E1 state transition, is linked to the 
countertransport of two K+ ions into the cell. In the absence of the substrate cations an 
equilibrium exists between the two conformational states (de Pont et al., 2003). In the 
presence of Na+ ions the E1 state is stabilized, whereas the E2 state is dominant in the 
presence of K+ ions (Post et al., 1975; Jørgensen, 1975; Jørgensen, 1977; Jørgensen, 2003). 
ATP hydrolysis drives the E1 → E2 transition, but this leaves the question about the driving 
force of the final step, the E2 → E1 state transition. It turns out that it is the binding energy 
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of ATP. ATP has been shown to bind with a high affinity to an ATPase in the E1 state, with 
a Kd of micromolar range, compaired to a Kd of a millimolar range measured for an enzyme 
in the E2 state (Cornelius & Skou, 1987; Goldshleger & Karlish, 1999; Teramachi et al., 
2002). Similar results have been obtained with sarcoplasmic Ca2+-ATPase, which has been 
demonstrated to transport two H+ as counter-ions during the fourth step (Levy et al., 1990; 
Yu et al., 1993).  
Hence, ATP has a dual role in the catalytic cycle. On the one hand it is the substrate of the 
phosphorylation reaction, which drives the E1 → E2 state conversion at submicromolar 
concentrations. On the other hand, at millimolar concentrations it shifts the conformational 
equilibrium to favor the E1 state, effectively enhancing the E2 → E1 transition. This is 
reflected in ATPase activity, which shows a biphasic dependance on the ATP concentration 
(Hua et al., 2002a; Inesi et al., 1967). While significant ATPase activity is observed at 
submillimolar ATP concentrations, the maximal activity is reached only at millimolar ATP 
concentrations, which corresponds to the intracellular ATP levels. The molecular basis for 
the different ATP affinities in E1 and E2 states is not known.  
    
3 Structural aspects of P-type ATPases 
3.1 Functional motifs and domain structure 
 
P-type ATPases in general share a relatively low sequence similarity. Also the number of 
transmembrane helices (TM-helices) varies (see chapter 3.6). Yet, all of them have a 
common core structure with two large cytoplasmic loops sandwiched between three pairs of 
TM-helices (Figure 3). Most P-type ATPases (P2 - P5-ATPases) are likely to share a 
topology of ten TM-helices, four of which reside on the C-terminal side of the core unit 
(Axelsen & Palmgren, 1998; Palmgren & Axelsen, 1998). 
While some of the P-type ATPases are composed of more than one subunit, the catalytic 
activity is always carried by a single polypeptide and the other chains serve as regulators or 
stabilizers. 
The smaller of the two large cytoplasmic loops contains a T214GES motif (the sequence 
numbering refers to sarcoplasmic Ca2+-ATPase). Mutation in this motif results in 
accumulation of the phosphointermediates (Portillo & Serrano, 1988; Clarke et al., 1990; 
Kato et al., 2003). Accordingly, it has been known formerly as the dephosphorylation 
domain. In the 3-D structure of Ca2+-ATPase this loop folds together with the N-terminus, 
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and this structural unit has been renamed an actuator domain (A domain) (Toyoshima et al., 
2000).  
ATPase activity resides in the larger cytoplasmic loop. This loop contains several 
conserved sequence motifs including the phosphorylation motif D351KTG. The aspartate-
351 is transiently phosphorylated during the catalytic cycle. Biochemical studies have not 
assigned a similarly clear function for the three other motifs, D601xxR, T625GDN and 
G702DGxNDxP. The two last motifs have been proposed to be involved in nucleotide 
binding and the latter also to function as a structural hinge (Taylor & Green, 1989; 
MacLennan et al., 1985). However, the crystal structures of Ca2+-ATPase argue against 
both of these ideas.  
 
 
 
Figure 3. Topological model of a P2-type ATPase showing the domain organization and the 
conserved sequence motifs. The helices which belong to the common core structure of the 
P-type ATPases are highlighted with dark grey. The loop that contains the T214GES motif is 
folded together with the N-terminus to form the A domain. This domain plays a role in the 
dephosphorylation step. The P domain is composed of the N- and C-terminal parts of the 
larger cytoplasmic loop. The D351KTG and G702DGxNDxP motifs are structural parts of the 
catalytic site. Aspartate-351 in the former motif is phosphorylated during the catalytic 
cycle. The N domain is situated in the middle of the P domain and does not contain motifs 
that would be conserved in all P-type ATPases. D601xxR motif resides at the interface of the 
P and N domains. The numbering corresponds to sarcoplasmic Ca2+-ATPase 
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 Already before the first high-resolution P-type ATPase structure was determined, the P-
type ATPase family was shown to belong to a halo acid dehalogenase (HAD) protein 
superfamily (Aravind, 1998). The structure of one HAD protein, DhlB, has been solved, 
which allowed the catalytic site of a P-type ATPase to be predicted by homology 
modelling. This model predicted the TGDN and GDGxNDxP motifs to be integral parts of 
the phosphorylation site (Ridder & Dijkstra, 1999).   
Additionally, comparison of the P-type ATPases with other HAD proteins revealed the 
domain organization of the larger cytoplasmic loop (Aravind, 1998). It turned out to be 
composed of a phosphorylation domain (P-domain) formed by the N- and C-terminal ends 
of the loop and of a nucleotide binding domain (N-domain) flanked by these sequences. 
The N-domain has propably been inserted into the P-domain during the evolution.  
   
3.2 Structure of the Ca2+-ATPase in the E1 state 
 
Sarcoplasmic Ca2+-ATPase was first crystallized in the presence of Ca2+ ions and the 
structure was solved at a resolution of 2.6 Å (Toyoshima et al., 2000). Soon after, crystals 
were obtained also in the absence of metal ions but in the presence of an ATPase inhibitor, 
thapsigargin, which was acting as a stabilizing ligand (Toyoshima & Nomura, 2002). The 
latter structure has been solved at a resolution of 3.1 Å. The first structure is believed to 
represent the E1 state and the latter the E2 state. 
 
Functional sites in the E1  structure 
Ca2+-ATPase crystallized in the presence of Ca2+ ions shows the enzyme in an orientation 
with the cytoplasmic domains spread wide apart from each other (Figure 4). Two Ca2+ ions 
are bound in the intramembraneous binding sites formed between helices M4, M5, M6 and 
M8. The nucleotide binding site in the N domain could be visualized by determining the 
structure from the crystals soaked with the nucleotide analog trinitrophenyl adenosine 
monophosphate (TNP-AMP). In the structure the distance between the Ca2+ binding sites 
and the phosphorylation site is about 50 Å, whereas the key aspartate is ~ 25 Å apart from 
the nucleotide binding site. To understand the mechanism of ion translocation driven by 
ATP hydrolysis, the interplay of all these sites has to be described in molecular terms. 
 
 17 
  
 
 18 
Figure 4. (Previous page) The structure of Ca2+-ATPase in the E1 (left) and E2 state (right). 
Domains are indicated with different colours: N domain with blue, P domain with red, A 
domain with green and M domain with grey. The key aspartate and nucleotide-binding 
residues are shown in yellow. The bound Ca2+ ions are shown as blue spheres. The domain 
movements, which take place during the state conversion, are also illustrated with arrows. 
The N domain and P domain incline towards the A domain, which does not move, but 
rotates around itself by a vertical axis. Domains themselves retain their structure practically 
unchanged, except the M domain, in which significant intradomain movements take place. 
 
 
Conserved sequence motifs of the P domain in the structure 
The E1 structure shows that the aspartate of the T625GDN motif interacts with the lysine of 
the D351KTG motif. The G702DGxNDxP motif, formerly known as the hinge motif, has the 
first aspartate in a position in which it could participate in the binding of the Mg2+ together 
with the threonine-353 of the D351KTG motif (Pedersen et al., 2000; Clausen et al., 2001). 
The structure does not support the idea that the G702DGxNDxP motif would function as a 
hinge. However, the D601xxR motif seems to be a true structural hinge. It is found in a 
stretch connecting the N and P domains and this area is known to be flexible to allow the N 
domain movements (see the next chapter). 
 
3.3 Ca2+-ATPase structure in the E2 state – the state conversion 
 
Comparison of structures of the E1 and E2 states 
The crystal structure of Ca2+-ATPase in the absence of Ca2+ ions has a rather different 
overall appearance. In contrast to the E1 structure, the head piece of Ca2+-ATPase in the E2 
state has a much more compact shape in which all three cytoplasmic domains are in contact 
with each other. Compared to the E1 state, the N domain in the E2 state is inclined roughly 
by 50º in respect to the P domain, which in turn rotates itself ~ 30º towards the A domain. 
The whole loop containing both domains moves laterally closer to the A domain, which 
rotates 110º around the axis perpendicular to the membrane level. All the previous 
transitions can be modelled as rigid body movements of the three domains without any 
significant changes taking place in the structure of the domains themselves, excluding the 
residues in the region connecting the N and P domains (T358NQMS and D601PPR). As a 
striking contrast, the M domain undergoes major structural changes during the state 
conversion, as evident by the significantly different arrangement of the membraneous part 
in the E1 and E2 structures (Toyoshima & Nomura, 2002; Toyoshima et al., 2003). In 
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relation to the E1 structure, in the E2 state the helices M1 and M2 are shifted upwards 
toward the cytoplasm, whereas the helices M3 and M4 are shifted downwards, both by 
about 5 Å. The M1 helix is the only one to move also laterally. In addition, the helices M3 
and M5 are strongly curved in opposite directions. The helices M7-M10 remain relatively 
unchanged. The helix M8 carries Glu908 that has been identified to be a metal ligand of the 
Ca2+ binding site I (Clarke et al., 1989; Toyoshima et al., 2000). The C-terminal helices 
M7-M10 are not known to be involved in any other function in the translocation process. 
Thus, it is not surprising that their equivalents are missing in P1B-ATPases. 
 
Interaction of the N and P domains  
In the E1 structure the nucleotide binding site is ~ 25 Å away from the phosphorylation site. 
In the E2 conformation the domain movements reduce this distance to about 15 Å, but it is 
still too much for the γ-phosphate of ATP bound to the nucleotide binding site to reach the 
key aspartate. It seems that a conformation must exist, in which the N domain is in an 
orientation that brings the two sites closer to each other. Interestingly, when the N domain 
is modelled into a low-resolution structure of H+-ATPase from Neurospora crassa, it is 
orientated in a way clearly different compared with the N domain in the E1 structure of 
Ca2+-ATPase (Kühlbrandt et al., 2002). In the H+-ATPase structure the N domain is in an 
almost vertical position in respect to the P domain (Auer et al., 1998). Still, both these 
structures are assumed to represent the E1 state. The apparent contradiction of the two 
dissimilar structures of the same state has been explained by proposing that the N domain in 
the E1 state would not be fixed, but it could move by Brownian motion (Xu et al., 2002; 
Kühlbrandt et al., 2002; Stokes & Green, 2003). Accordingly, the Ca2+-ATPase and H+-
ATPase structures can be considered as snapshots of conformations that the enzyme can 
adopt in the E1 state. It has been demonstrated by molecular modelling that the N domain 
can be rotated using rigid body movements to bring K492 to a distance of 4 Å from R678 in 
the E1 structure of Ca2+-ATPase (Xu et al., 2002). These two residues have been shown to 
be crosslinked by glutaraldehyde while the enzyme resides in the E1 state proving that the N 
domain is able to adopt an orientation similar to that in the model (McIntosh, 1992).  
 
The role of the A domain  
The catalytic site performs two different tasks during the catalytic cycle depending on 
whether the enzyme is in the E1 or in the E2 state. In the former case it facilitates the 
formation of the aspartyl phosphate bond, whereas in the latter case it catalyzes a 
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nucleophilic attack by a water molecule on the very same bond. Both of these reactions 
require Mg2+ to be present as a cofactor. However, experimental evidence indicates that the 
coordination sphere of Mg2+ is significantly different in the two conformations. There is no 
Mg2+ ion present in either the E1 or E2 crystal structures, but the surroundings of the Mg2+ 
binding site have been probed by using an Fe2+-catalyzed cleavage technique (Goldshleger 
& Karlish, 1997). Several divalent cations can be used to replace Mg2+ as a cofactor. If 
Mg2+ is substituted by Fe2+, ~ 25% ATPase activity can be achieved with Ca2+-ATPase 
(Fukushima & Post 1978, Hua et al., 2002b). Unlike Mg2+, in the presence of H2O2 and 
ascorbate Fe2+ catalyzes oxygen radical production by Fenton chemistry. Highly reactive 
radical species cleave the peptide bonds in the vicinity of Fe2+. Na+/K+-ATPase cleaved by 
ATP-Fe2+ in the E1 state is cleaved at the sites 440VAGDA (N domain) and 712VNDS (P 
domain), which is consistent with the prediction that the ATP binding site comes close to 
the phosphorylation site (Patchornik et al., 2000). When the enzyme is cleaved while in the 
E2 state, the first cleavage is not observed, but instead a new fragment appears showing a 
cleavage site at 214ESE (Patchornik et al., 2000; Goldshleger & Karlish, 1999). This is part 
of the TGES motif located in the A domain. In the E2 structure the TGES loop comes close 
to the catalytic site while the nucleotide binding site is no longer associated with the 
phosphorylation site. Thus, in the E1~P → E2-P state conversion A domain replaces the N 
domain from the active surface of the P domain and effectively turns the enzyme to 
catalyze the hydrolysis of the aspartyl phosphate. In contrast, when the enzyme reverts back 
to the E1 state, the A domain moves away from the active site. The structural model is 
supported by the mutagenesis data showing mutations in the A domain increase the stability 
of phosphointermediates, without affecting the ATP phosphorylation step itself (Kato et al., 
2003; Clarke et al., 1990; Toustrup-Jensen et al., 2003). 
 
3.4 Cation-binding sites and the ion translocation pathway 
 
According to the standard model, the Ca2+-binding sites should be accessible from the 
cytoplasm in the E1 state. The channel should stay open even when the cations are bound, 
until the enzyme is  phosphorylated by ATP. This has also been observed experimentally; 
bound 45Ca2+ ions are exchangeable with soluble 40Ca2+ ions in the absence of ATP 
(Dupont, 1982; Inesi, 1987), but become occluded following ATP phosphorylation (Sumida 
& Tonomura, 1974; Dupont, 1980). In the E1 structure two Ca2+ ions are bound to the sites 
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in the middle of the helices M4-M6 and M8. The binding sites are formed by several acidic 
residues, which neutralize the strong positive charge of the Ca2+ ions. A clear path from the 
cytoplasm to the cation binding sites has not been identified, but a channel surrounded by 
the helices M2, M4 and M6 has been proposed (Toyoshima et al., 2000).    
On the other hand, the E1-E2 model suggests that in the E2 conformation the metal binding 
sites should be accessible from the lumenal side of the membrane. Surprisingly, there is no 
such path in the E2 structure, but a clear path is seen to the Ca2+-binding sites from the 
cytoplasmic side. The pathway starts between the M1 and M3 helices and ends up to the 
E309 in the M domain. Mutations in a stretch K252LDE and G257EQL in the M3 affect 
strongly the release rate of bound Ca2+ ions supporting this area to be involved in the ion 
translocation (Andersen et al., 2003). Glu-309 is one of the residues forming the Ca2+-
binding site II in the E1 structure, whereas in the E2 structure it is actually pointing away 
from the binding site. Rearrangements of this residue might be part of the gating 
mechanism that regulates the access to the metal binding sites from the cytoplasmic side. 
This still leaves the question about how the cations are eventually released to the lumenal 
side. A likely explanation is that the lumenal gate of the metal-binding sites is only 
transiently open during the E1P-E2P state conversion, or in the E2P state.  
 
3.5 Nucleotide-binding site and orientation of the ATP molecule 
 
Structure of the ATP-binding site 
Many nucleotide-utilizing  proteins have special nucleotide-binding motifs which are rich 
in glycines. These include the GxxGxGK motif, known as the P-loop, and GxGxxG, a 
motif found in protein kinases (Saraste et al., 1990; Bossemeyer, 1994; Kinoshita et al., 
1999; Vetter & Wittinghofer, 1999). Glycine-rich motifs were likely formed by convergent 
evolution, as they are found in otherwise completely unrelated proteins (Via et al., 2000). In 
P-loop structures the dihedral angles of the glycines are not allowed for residues with side 
chains, whereas in protein kinases the lack of a side chain is utilized to provide a space for 
phosphate groups of a nucleotide to fit in a binding site (Bossemeyer, 1994). In both cases 
the glycine motifs fold into a loop, which interacts with the phosphate groups by the 
mainchain amide groups (Kinoshita et al., 1999). However, P-type ATPases are considered 
to be an example of a nucleotide-hydrolyzing protein family that does not have glycine-rich 
motifs (Vetter & Wittinghofer, 1999).  
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The N domain does not possess any sequence motifs which would be common to all P-type 
ATPases. Still, there are several individual residues highly conserved within the P2-P5 
subfamilies. Mutagenesis (McIntosh et al., 1996; Kubala et al., 2002; Kubala et al., 2003; 
Jacobsen et al., 2002; Clausen et al., 2003), NMR (Abu-Abed et al., 2002), FeATP-
catalyzed cleavage (Hua et al., 2002b; Patchornik et al., 2002; Patchornik et al., 2000), 
labelling (Mitchinson et al., 1982; Hua et al., 2002a) and crosslinking experiments have 
shown three basic residues (K492, K515, R560) and a phenyl alanine F487 to be the key 
residues forming the ATP-binding site of Ca2+- and Na+/K+-ATPases (Ca2+-ATPase 
numbering, see alignment in Figure 8). Consistent with this data, the structure of Ca2+-
ATPase determined from the E1 crystals soaked with TNP-AMP solution shows the 
nucleotide analog bound in a site formed by these residues (Figure 5A). 
 
 
 
Figure 5. A) TNP-AMP bound in the Ca2+-ATPase in the E1 state (Toyoshima et al., 2000). 
The structure was gained by soaking the protein crystals in TNP-AMP solution. The figure 
is modified from Toyoshima et al., 2000. B) ATP bound in the N domain of Na+/K+-
ATPase. The ATP molecule is highlighted in yellow. The structure of the domain with the 
nucleotide bound was solved by NMR (Hilge et al., 2003). The figure is modified from 
Hilge et al., 2003.  
 
 
Orientation of the bound nucleotide  
When considering the orientation of the nucleotide in the binding pocket, the picture gained 
using TNP-AMP should be viewed cautiously. The bulky and hydrophobic TNP moiety is 
known to affect the binding affinity of a nucleotide analog (Watanabe & Inesi, 1982) and it 
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might cause the adenine ring to bind in non-native way. Also, the analog does not provide 
information about the alignment of the β- and γ-phosphates, which are missing in this 
compound. Several proposals of the binding of an ATP molecule have been put forth by 
using molecular modelling (Ma et al., 2003; Munson et al., 2003; Patchornik et al., 2002; 
Ettrich et al., 2001), but until recently there was little experimental data about the exact 
orientation of the nucleotide in the binding site.  
An NMR structure of the N-domain (containing residues Q376-P588) of Na+/K+-ATPase with 
an ATP molecule bound has been described in Hilge et al., 2003 (Figure 5B). The structure 
shows the nucleotide to form the binding interactions mainly with its purine and sugar 
rings, leaving the phosphate groups exposed to the solvent. F475 (F487 in Ca2+-ATPase), a 
critical residue for the ATP binding, provides an aromatic ring that binds the purine ring of 
the ATP with a hydrophobic stacking interaction. The strictly conserved K480 (which 
corresponds to K492 in Ca2+-ATPase) stabilizes the negatively charged α-phosphate of ATP 
with its positive charge. Instead, the β- and γ-phosphates seem to be relatively free to move. 
In the structure they point away from D443. This residue is proposed to be coordinating the 
Mg2+ ion, because Fe2+-ATP causes a cleavage at this site (Patchornik et al., 2002). 
However, D443 is not conserved and no analogous cleavage is observed, when the 
experiment is conducted with Ca2+-ATPase. Instead, in this case Fe2+-ATP causes oxidation 
of a residue nearby, T441, suggesting that the region could be involved in the Mg2+ binding 
also in Ca2+-ATPase (Hua et al., 2002b).  
The structural and biochemical findings discussed above are consistent with the observation 
that even though the true substrate in biological conditions is MgATP, both Mg2+ and ATP 
can bind independently and in a random order (Reinstein & Jencks, 1993). The structure 
explains how ATP binds effectively without Mg2+ and also how the latter can bind without 
the need for the nucleotide to dissociate first. 
  
3.6 Structural organization of P1B-type ATPases 
 
Special structural features of P1B-ATPase 
Sequence analysis suggests that P1B-ATPases do not share the topology of the ten TM-
helices with the rest of the P-type ATPases. Instead, they are predicted to contain six or 
eight TM-helices (Møller et al., 1996; Lutsenko & Kaplan, 1995; Solioz & Vulpe, 1996). 
Moreover, when compared to other P-type ATPases, the helices are organized in a different 
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way (Figure 6, compare with Figure 3). An extra pair of TM-helices resides N-terminally to 
the common core of the P-type ATPases, while four helices are missing from the C-
terminus. This topology is supported by experiments conducted with CadA and CopA from 
Staphylococcus aureus (Tsai et al., 2002) and Helicobacter pylori (Melchers et al., 1996; 
Bayle et al., 1998). 
 
 
 
 
Figure 6. Topological model of a P1B-ATPase. Note that both the number and the order of 
TM-helices differs from the topology of a non-heavy-metal-transporting P-type ATPase 
(compare with the figure 3). TM-helices with darker color belong to the core unit common 
to all P-type ATPases. In addition to motifs conserved in all P-type ATPases, also P1B-
ATPase specific motifs are shown. The CxxC and the CPx motifs are putative metal-
binding sites. In the former motif x is any residue, whereas in the latter it is a Cys, His or 
Ser. An HP motif is always found in the N domain and mutation of the His to Gln is the 
most common WD mutation in the Western population. The GxGxxA is a motif also 
located in the N domain. The last residue can be also a Gly, Ser or Cys. The numbering 
corresponds to ZntA sequence. 
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In addition to the differences in the TM part, there are a number of sequence motifs which 
are unique for heavy-metal-transporting ATPases. A putative intramembraneous metal-
binding site, the CPx motif, is invariantly found at the sixth TM-helix (Solioz & Vulpe, 
1996; Lutsenko & Kaplan, 1995). Two motifs are found in the N domain, an HP motif 
(Solioz & Vulpe, 1996; Lutsenko & Kaplan, 1995) and a protein kinase-like motif 
GxGxxG/A (III). Most of P1B-type ATPases also contain one to six copies of metal-binding 
sites in their N-terminus, carrying either a CxxC motif, or a sequence rich in histidines 
(Argüello, 2003). These domains are discussed more in detail in the chapter 5.2. 
 
4 P-type ATPases in heavy metal transport – Wilson disease 
4.1 Overview of the biology of heavy metals 
 
Heavy metals play a dual role in biology. On the one hand, metal ions like Cu+/Cu2+, Zn2+ 
and Fe2+/Fe3+ serve as important co-factors of enzymes, being able to catalyze a variety of 
reactions, and stabilize protein structures. On the other hand, other metal ions like Pb2+, 
Cd2+ and Hg2+ are purely toxic. Essential metal ions can also become poisonous when 
present in excess. Exceeding the capacity of the metal handling machinery results in mainly 
misincorporation of metal ions into vital proteins and oxygen radical production (Maret et 
al., 1999; Gazaryan et al., 2002; Videla et al., 2003). The nature of heavy metals makes it 
imperative that cells must be able to keep the intracellular concentrations of heavy metal 
ions within a narrow range.  
 
Cytosolic control of heavy metals 
According to the current view, heavy metal ions, unlike alkaline and earth-alkaline metal 
ions, do not exist as free ions in the cytosol, but are always bound to carrier molecules such 
as glutathione (GSH), metallothioneins, and metal chaperones (Finney & O’Halloran, 
2003). In addition to these primary carriers, many other small molecules, including amino 
acids and nucleotides can bind metal ions non-specifically. According the current estimates 
the concentration of the free cytosolic Zn2+ and Cu+ ions is in a femtomolar range, even 
though the total intracellular concentrations of these ions are about 100 µM and 10 µM 
respectively (Changela et al., 2003; Outten & O’Halloran, 2001; Rae et al., 1999). There is 
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little experimental data on how other metal ions are handled inside a cell, but it is assumed 
that the same principles apply also to other vital heavy metal ions, such as Fe2+ and Co2+.  
 
Metal chaperones 
Metal chaperones provide a coordinated way to incorporate metal ions into proteins (Field 
et al., 2002; Lu et al., 2003). They are small intracellular proteins that bind metal ions and 
deliver them specifically to their target protein. In prokaryotes there is only one protein, 
which is known to function as a metal chaperone. CopZ has been shown to interact with 
CopA copper importer and to deliver copper to CopY repressor protein in Enterococcus 
hirea (Multhaup et al., 2001; Cobine et al., 1999). Instead, in Bacillus subtilis the 
homologous protein by the same name provides copper to a copper exporting protein 
(Banci et al., 2003). In eukaryotes three chaperones, Cco, Cox17 and Atx1 are known, 
which were first found in Saccharomyces cerevisiase. They transfer copper to Zn,Cu -
superoxide dismutase, cytochrome c oxidase and for a Cu+-ATPase Ccc2 respectively 
(Glerum et al., 1996; Lin et al., 1997; Pufahl et al., 1997). Atx1 has a human counterpart, 
called HAH1, or Atox1. It carries copper to two human Cu+-ATPases called Wilson and 
Menkes disease proteins (Hamza et al., 1999), which are discussed in the next chapter. 
Up to date, no other metallochaperones are known in addition to the three listed above. It 
remains to be seen if there are chaperones also for other copper enzymes and if any 
chaperone capable of transferring a metal ion other than copper exists. 
 
Import and export of heavy metals 
All organisms have a variety of metal uptake systems, which differ in their specificity and 
affinity. Specific metal importers are usually tightly regulated, but metal ions can 
accumulate in a cell via transporters with a broad specificity. For example, the human iron 
transporter DMT1 has been shown to be able to transport almost any divalent cation 
(Gunshin et al., 1997; Garrick et al., 2003). Metal ions can also infiltrate into a cell by using 
molecular mimicry, which means that they are translocated by a transporter destined for an 
entirely different purpose (Rosen, 2002; Beard et al., 2000). Example of the latter case is 
the accumulation of Mn2+, Co2+ and Zn2+ ions via the phosphate transporter (Jensen et al., 
2003; Beard et al., 2000; Van Veen et al., 1994). Excess metal ions are detoxified either by 
capturing them with metallothioneins, or by storing them in vacuoles or other vesicles. 
These metal ions are finally removed when the cells are sloughed off from the epithelial 
layer. The role of the metal storage system is well established in metal detoxification 
 27 
(Thiele et al., 1986; Hamer et al.,1985), but whether this pool of metal ions can be used in 
the biosynthesis of metalloproteins has not been clearly demonstrated. However, the 
experimental evidence supports the idea that metals bound to glutathione (GSH) can be 
utilized this way (da Costa Ferreira et al., 1993; Freedman et al., 1989; Ciriolo et al., 1990; 
Brouwer & Brouwer-Hoexum, 1992; Musci et al., 1996). 
 
 
 
 
Figure 7. Simplistic scheme of zinc metabolism in E. coli. Zinc is imported via ZnuC 
transporter (Patzer & Hantke, 1998) and inside the cell it is likely to exist bound to some 
carrier molecule. No metallochaperones are known to exist in E. coli, but GSH might play a 
similar role (see the text). Zinc in this pool can be delivered to zinc proteins including many 
enzymes and the ZntR and Zur proteins that regulate the ZntA and ZnuC genes respectively 
(Brocklehurst et al., 1999; Silke & Hantke, 1998). Excess zinc is removed by ZntA P-type 
ATPase. In reality, ZntA and ZnuC do not exist in the cell at the same time because one 
gene is always repressed when the other is active (Outten & O’Halloran, 2001). 
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Not all cells have vacuoli or metallothioneins. In such cases, effective protection against 
metal poisoning can be gained by pumping excess ions out of the cells. The majority of the 
prokaryotic P1B-ATPases are used for this purpose (Nies, 2003). Consequently, they are 
expressed only in the presence of high concentrations of metal ions in the environment 
(Brocklehurst, et al., 1999; Petersen & Møller, 2000). A few cases have been reported in 
which P1B-type ATPases are likely to function as copper importers (Francis et al., 1997; 
Odermatt et al., 1993; Solioz & Odermatt, 1995). In contrast, eukaryotes utilize these 
ATPases to deliver copper to intracellular compartments, like the Golgi complex (Shim & 
Harris, 2003). The same transporters can be used also to maintain the metal homeostasis in 
higher organisms by means of copper-dependent trafficking (see chapter 4.4).  
The subject of this work is ZntA, a zinc exporting ATPase that protects Escherichia coli 
from high levels of zinc (Beard et al., 1997). Key components of a bacterial heavy metal 
homeostasis system is summarized in Figure 7, by using E. coli’s zinc metabolism as an 
example.  
 
4.2 ZntA – a zinc-translocating P1B-ATPase from Escherichia coli 
 
ZntA is a heavy-metal-transporting P-type ATPase from Escherichia coli. It has been 
demonstrated to drive extrusion of Zn2+ and Cd2+ ions across the cell membrane (Rensing et 
al., 1997). Pb2+ is also a potent stimulator of the ATPase activity like Zn2+ and Cd2+ ions 
(Rensing et al., 1998), but there is no radioactive isotope for Pb2+ which could be used to 
show the actual ion transport to occur. However, disruption of the ZntA gene abolishes the 
ability of the bacterium to grow in the presence of high concentrations of lead, zinc and 
cadmium salts, which essentially proves that the ATPase functions to export all the three 
cations (Beard et al., 1997; Rensing et al., 1997; Rensing et al., 1998). The growth of the 
∆ZntA strain is not disturbed by the presence of metals other than Zn2+, Cd2+ and Pb2+. 
However, this does not exclude the possibility that ZntA has additional substrate cations, 
because there might exist other systems that could compensate the lack of ZntA by 
detoxifying these metals. Cu2+, Ni2+ and Co2+ have been shown to partially activate ZntA 
(See chapter 3.1 in the results section), but it is unclear whether these cations are actually 
translocated across the membrane (I; Hou et Mitra 2003).   
ZntA is not a housekeeping gene; it is expressed only when there is Zn2+, Cd2+, or Pb2+ 
present in the environment of the cell (Brocklehurst et al., 1999). ZntA gene is regulated by 
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ZntR, a zinc-binding protein that activates the expression (Brocklehurst et al., 1999). ZntR 
is extremely sensitive to the presence of zinc; the expression level starts to rise already at 
femtomolar (10-15) intracellular zinc concentration (Outten & O’Halloran, 2001).  
 
 
 
Figure 8. Comparison of the ZntA and Wilson disease protein (WND). The black boxes 
represent metal-binding domains (MBD), whereas TM-helices are represented with grey. 
Other cytoplasmic domains are indicated with labels. 
 
 
The operon contains also another gene, predicted to code for a membrane protein with an 
unknown function (Sofia et al., 1994). However, ZntA can be expressed and purified in an 
active form without this protein (expression and activity reported in I, purification results 
not shown. Activity of the purified protein reported in Sharma et al., 2000). 
Up to date ZntA remains the best characterized P1B-ATPase. It is used in this work to study 
the consequences of Wilson disease mutations by introducing disease mutations into ZntA. 
The metal specificity of the two proteins is different, WND is a Cu+-ATPase and ZntA is  
transporting divalent cations like Zn2+ and Cd2+. Still, the overall identity of the two 
proteins is ~30%. The size of WND is almost twice as large as that of ZntA, mainly 
because there are six MBDs in WND, while only one is found in ZntA (Figure 8). WND 
and Wilson disease are discussed in the next chapters. 
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4.3 Human copper metabolism disorders – Wilson and Menkes diseases  
 
There are two diseases, known as Wilson and Menkes diseases, which manifest severe 
consequences of an imbalance of heavy metal homeostasis. The former is a copper 
accumulation disorder, while the latter is a copper deprivation state (for a recent review, see 
Shim & Harris, 2003). 
 
Menkes disease 
Several Cu-enzymes are known to be vital for the human beings, such as cytochrome c 
oxidase (Cox), superoxide dismutase (SOD1) and lysyl oxidase (Shim &Harris, 2003). Cox 
is a terminal oxidase of the respiratory chain (Richter & Ludwig, 2003) and SOD1 is 
involved in radical scavenging by metabolizing superoxide radicals into hydrogen peroxide 
(Fridovich, 1997). Lysyl oxidase is required for the formation of connective tissue making 
the collagen crosslinks (Rucker et al., 1998). A failure to meet the body’s copper 
requirement has therefore serious consequences. Nutritional lack of copper is very rare, but 
a copper depletion state may develop as a result of a genetic disorder, called Menkes 
disease (Menkes et al., 1962). In this disease copper transport from intestinal cells to the 
circulation is blocked (Danks et al., 1972). Hence, copper accumulates in the cells of the 
intestinal wall, whilst all other tissues are suffering from copper deficiency. The symptoms 
include impaired growth, defects of connective tissue, kinky hair, hypothermia and 
neurological degeneration (Menkes et al., 1962; Danks et al., 1972). This difficult condition 
is treated by administrating copper to the circulation as a Cu-His compound (Sarkar, 1999), 
but even when treated, the patients often die during the early stages of life. 
 
Wilson disease 
Lack of copper has devastating results, but also too high an amount of copper leads to a 
pathological condition. Copper toxicosis, like copper deficiency, is rarely encountered, but 
it too can be caused by a hereditary disease, which is called Wilson disease. The first cases 
were described by a Finnish physician E.A. Homén, who reported a development of 
neurological symptoms like muscle stiffness and tremor (Homén, 1890a; Homén, 1890b). 
He also reported the most important post-mortem findings of the patients: badly 
degenerated lenticular nuclei in the brain and liver chirrosis (Homén, 1892). More than 20 
years later, S.A. Kinnier Wilson wrote an extensive article about the disease, reviewing 
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Homén’s patients together with other cases with similar symptoms and post-mortem 
findings (Wilson, 1912). He called the disease “progressive lenticular degeneration”, but it 
soon got named after him. The disease is also known as hepato-lenticular degeneration. It 
took several decades before the symptoms were connected to the accumulation of copper in 
affected organs (Cumings, 1948). Finally, the fundamental basis of the disease was 
discovered when the Wilson disease gene was cloned simultaneously by three research 
groups. It turned out to be a copper-transporting P-type ATPase similar to Menkes disease 
gene cloned earlier in the same year (Tanzi et al., 1993; Bull et al., 1993; Yamaguchi et al., 
1993; Vulpe et al., 1993; Chelly et al., 1993; Mercer et al., 1993). 
Originally Wilson disease was described as a neurological disorder associated with liver 
chirrosis (Homén, 1890a; Homén, 1890b; Homén, 1892; Wilson, 1912), but later it was 
found to manifest also as an acute, or chronic liver disease in children and adolescents. 
While the severity and onset age of the disease are highly variable, the patients can be 
divided into two groups on the basis of whether they display mainly neurological or hepatic 
symptoms (Ferenci, 2003). 
There are two principal means to treat the disease (Sarkar, 1999; Subramanian et al., 2002). 
The first one is to use a copper chelator, such as penicillamine. The metal ions in the 
plasma are harvested by the drug and the metal-chelator complex is finally removed via 
urinal excretion. The other strategy is the administration of zinc, which is a potent inducer 
of metallothionein expression. The metallothionein in the intestinal cells binds copper with 
much higher affinity than zinc, thus reducing the copper delivery to the circulation. The 
body gets rid of this copper when the cells are eventually sloughed off from the intestinal 
wall. 
 
Genetic basis of the diseases 
The majority of Menkes disease mutations are small insertions, deletions or splice site 
mutations, which result in a severe condition (Hsi and Cox, 2004; Chelly et al., 1993; 
Mercer et al., 1993). Point mutations are also found, but most of them are nonsense 
mutations and only 17% of all MNK mutations are missense mutations (Hsi and Cox, 
2004). Thus, the classical form of Menkes disease develops because of a non-functional or 
an absent ATPase. Milder forms of Menkes disease have been also been described, 
including the occipital horn syndrome (Kaler et al., 1994; Møller et al., 2000), that 
comprise roughly 5-10% of the cases. In contrast, Wilson disease occurs largely due to 
missense mutations, over a hundred of which have been described so far (Hsi and Cox, 
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2004; Cox, 2002). Unlike in Menkes disease, it seems that in most cases the mutation do 
not lead to complete loss of Cu-ATPase activity (Thomas et al., 1995; Shah et al., 1997). 
 
4.4 Multiple roles of MNK and WND copper pumps 
 
Menkes disease and Wilson disease ATPases share about 60% identity and they are 
functionally interchangeable (La Fontaine et al., 1998). Still, the outcomes of the two 
diseases are completely the opposite. This is due to the different expression patterns of the 
genes: Menkes disease protein (MNK) is expressed in almost every tissue excluding the 
liver (Vulpe et al., 1993; Chelly et al., 1993), while Wilson disease protein (WND) is 
expressed mainly in the liver (Tanzi et al., 1993; Bull et al., 1993). 
 
MNK and WND in copper homeostasis 
MNK is the pump that delivers copper to the circulation from the intestinal cells during 
copper uptake (Linder & Hazegh-Azam, 1996; Shim & Harris, 2003). In Menkes disease 
this step is abolished, which explains the accumulation of copper in intestinal cells and the 
systemic lack of this metal in all other tissues. In contrast, WND functions in the liver in the 
excretory route of copper (Linder & Hazegh-Azam, 1996; Shim & Harris, 2003). The only 
way for human beings to secrete copper in significant amounts is via bile, synthesized in 
the liver. In order to get into bile canaliculae, the cytoplasmic copper ions in a hepatocyte 
have to be pumped out by WND. It is straightforward to connect the hepatic accumulation 
of copper with ATPase impaired by a Wilson disease mutation. The basis of the copper-
induced neurological degeneration, however, is poorly understood. WND is not expressed 
exclusively in the liver, as significant WND expression is seen in the kidney and the 
placenta and minor levels are detected also in other tissues, including the brain (Bull et al., 
1993; Tanzi et al., 1993). In principle, when mutated, this cerebrally expressed ATPase 
could be the cause of the copper accumulation in the brain. However, Wilson disease 
patients who are treated with liver transplantation show a marked improvent of both the 
hepatic and neurological symptoms, unless the nervous tissue is already severely damaged 
(Eghtesad et al., 1999; Schilsky et al., 1994). This implies that while the cerebral WND 
might play a part in the development of the neurological symptoms, it is not the primary 
cause for the degeneration of the nervous tissue. It has been suggested that liver damage 
leads to the leakage of copper to the circulation and somehow this copper accumulates in 
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the brain (Cox & Moore, 2002). The details of this process are largely unknown. 
Apolipoprotein E genotype ε3/ε3 has been observed to be connected to a late-onset age of 
Wilson disease, indicating that also other genes in addition to Atp7B itself can affect the 
outcome of the disease (Schiefermeier et al., 2000).    
 
Cellular location of WND and MNK 
Considering the tasks of MNK and WND in the export of copper from the cell, one would 
expect to find the ATPases at the plasma membrane. Surprisingly, immunomicroscopy has 
revealed that both proteins are intracellular and localize in the trans-Golgi network (TGN) 
(Yamaguchi et al., 1996; Dierick et al., 1997; Hung et al., 1997). The Golgi retention signal 
has been proposed to be associated in the third TM-helix, as the alternatively spliced MNK 
missing TM-helices three and four fails to localize in TGN and a plasmamembrane 
localizing protein CD8 fused with the TM3 is found in the TGN (Francis et al., 1998).  
This location is linked to the function of the ATPases in the delivery of copper for the 
synthesis of Cu-enzymes in the secretory route. One such enzyme is lysyl oxidase, which 
cannot function properly when copper transfer to the Golgi lumen is impaired in Menkes 
disease (Rucker et al., 1998). Another example is ceruloplasmin, the most prominent 
copper protein in plasma. This multicopper oxidase is synthesized in the liver, where 
copper needed for its biosynthesis is provided by WND (Murata et al., 1995). 
Ceruloplasmin is a multifunctional protein involved in copper transfer and antioxidation, 
but its main function seems to be mobilization of the intracellular iron. Aceruloplasminemia 
is a rare hereditary condition characterized as an iron accumulation disorder due to the 
absence of ceruloplasmin (Yoshida et al., 1995).  
Analogously, a copper ATPase in S. cerevisiae, Ccc2, is found to transport copper into the 
Golgi lumen, where it is incorporated into Fet3 oxidase (Yuan et al., 1995; Yuan et al., 
1997). Fet3 is a ceruloplasmin-like multicopper enzyme, which is a critical component of 
the high-affinity iron uptake system. Both MNK and WND can replace Ccc2 in a ∆Ccc2 
strain (Hung et al., 1997), suggesting that the universal task of eukaryotic copper ATPases 
is the intracellular copper transport.  
The yeast system has been used widely as an in vivo copper transport activity assay (Forbes 
& Cox, 1998; Forbes et al., 1999; Payne & Gitlin, 1998; Iida et al., 1998; Sambongi et al., 
1997; Borjigin et al., 1999). This has been conducted by replacing Ccc2 with other Cu-
ATPases and measuring the growth of this yeast strain in iron-deficient environment.  
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Copper-dependent trafficking 
WND and MNK do not function only in the metalloprotein biogenesis, but they are also 
involved in the copper homeostasis of the cell and the whole organism (Linder & Hazegh-
Azam, 1996). Therefore, it was a surprise to find them to be intracellular proteins. The 
scheme started to make sense, when both MNK and WND were found to undergo copper-
dependent trafficking. At elevated copper concentrations MNK moves from the Golgi 
complex to the plasma membrane (Petris et al., 1996), whereas WND is transferred to a 
vesicular compartment (Hung et al., 1997). WND has also been reported to exist at the 
plasma membrane, but these results are controversial (Schaeffer et al., 1999; Roelofsen et 
al., 2000). The trafficking is linked to a reversible phosphorylation event distinct from the 
transient phosphorylation taking place during the catalytic cycle (Vanderwerf et al., 2001; 
Voskoboinik et al., 2003b). In contrast to the catalytic acylphosphate intermediate, this 
regulatory phosphorylation is not sensitive to hydroxylamine. When the copper 
concentrations decreases, the ATPase is dephosphorylated and subsequently returns to the 
TGN. 
The expression of WND has been shown to be modulated by copper, although it is 
constitutively expressed (Oh et al., 2002; Schilsky et al., 1998). The significance of this 
regulation is not clear.  
Copper-dependent trafficking is a way to regulate the copper flow. It can be directed either 
to the Golgi lumen to be incorporated into luminal metalloproteins, or to the extracellular 
space to support copper delivery to the other cells and eliminate excess copper. 
 
4.5 Genotype/phenotype correlation in Wilson disease 
 
The world-wide prevalence of Wilson disease is ~ 30 per million which means that the 
carrier frequency is 1 per 90 (Figus et al., 1995; Petrukhin et al., 1993). So far over a 
hundred disease-causing missense mutations have been reported (Cox, 2002). In addition, 
also deletions, insertions and non-sense mutations have been reported. As most of the 
patients are compound heterozygotes (Thomas et al., 1995; Riordan & Williams, 2001), a 
considerable amount of different genotypes exists. Consequently, there is a large variety of 
disease phenotypes and no single diagnostic test can confirm Wilson disease with 100% 
certainty (Ferenci et al., 2003). This can be achieved by using genetic testing, but it is very 
laborious owing to the large size (~ 80 kb) of the ATP7B gene (Waldenström et al., 1996).  
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The complexity of genotypes and phenotypes makes it difficult to assign any correlations 
between them (Thomas et al., 1995). For the most common mutations, patients exist in 
significant numbers allowing comparisons, but the phenotypes display large variation even 
among the subjects sharing exactly the same ATP7B genotype. One can still draw some 
conclusions, which are discussed below. 
 
Mutation H1069Q  
Among European and North American population H1069Q is the most common mutation 
(Riordan & Williams, 2001; Loudianos et al., 2000). Homozygous patients carrying this 
mutation have a mean onset age of about 20 years (17 years in all Wilson disease patients) 
(Shah et al., 1997; Houwen et al., 1995). In one study, the proportion of patients displaying 
mainly hepatic or neurological manifestations is roughly equal (Shah et al., 1997), whereas 
in an other study most patients had neurological symptoms (Czlonkowska et al., 1997). 
Hepatic copper accumulation varies from normal to six-fold and ceruloplasmin levels from 
normal to zero (Shah et al., 1997).  
The histidine-1069 is strictly conserved among heavy-metal-transporting ATPases and has 
a complex role in the catalytic cycle (see chapter 5.3). It can be concluded that H1069Q is a 
relatively mild mutation, because of its tendency to result in a late onset of the disease. 
The biochemical findings are discussed in the chapter 2.3 in the results section. 
 
Mutation R778L 
In Asia, the mutation R778L is the most prevalent one. It is associated with an early onset 
of the disease (mean onset at 14 years of age) and with the prevalence of hepatic symptoms 
(in one study only 3 of 18 patients displayed neurological symptoms) (Wu et al., 2001; 
Okada et al., 2000).  
The arginine-778 is not completely conserved and no function has been assigned to it so 
far. In contrast to H1069Q mutation, R778L seems to have a strong inhibitory effect on 
WND. This conclusion is supported by the observation that MNK carrying the R778L 
mutation is a poor substitute of Ccc2 in ∆Ccc2 yeast strain (Forbes & Cox, 1998).  
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4.6 Molecular basis of the Wilson disease – a trafficking defect? 
 
Soon after the Wilson disease gene was found, it was reported that the mutation H1069Q 
causes a trafficking defect (Payne et al., 1998). Instead of residing at the TGN, 
immunomicroscopy revealed that the mutant protein was retained at the endoplasmic 
reticulum (ER). At a lower temperature WND could reach the TGN, but it was still unable 
to undergo copper-dependent trafficking. These findings started a discussion about the 
possibility that Wilson disease might develop not because of an impaired function of the 
ATPase, but due to its mislocalization. In support of this hypothesis, several other Wilson 
disease mutations were also reported to cause a trafficking defect (Forbes & Cox, 2000; 
Forbes & Cox, 1998).  
A failure to leave ER implies that the folding of the protein is abnormal. It is a general 
observation that misfolded proteins are arrested in the ER because they are recognized by 
the quality-checking machinery (Seng et al., 1990; Deen et al., 1995; Kopito, 1997). At 
lower temperatures the mutated proteins might fold correctly and be able to escape to the 
Golgi (Denning et al., 1992). In contrast to this type of general structural defect, which 
leads to mislocalization of the protein, the impaired copper-dependent trafficking of the 
proteins that are able to get to the TGN suggests that the mutations have also a more 
specific effect on the enzyme. It is possible that they affect regions which are responsible 
for ATPase trafficking. 
 
Is the trafficking defect a primary effect of the mutations?   
The recent evidence however implies that the activity and location of the ATPase are not 
completely independent properties. First of all, destroying the catalytic site by replacing the 
key aspartate abolishes trafficking completely (Petris et al., 2002). On the other hand, The 
Menkes disease mutation L873R (Ogawa et al., 1999), or replacement of the TGE motif of 
WND with the AAA sequence (Petris et al., 2002), both of which impaire 
dephosphorylation step (Clarke et al., 1990; Portillo & Serrano, 1988), result in a protein 
that is constitutively located in the vesicular compartment. These results demonstrate that 
trafficking is connected to the formation of the catalytic phosphointermediate. In the 
chapter 4.4 it was mentioned that trafficking is linked to a phosphorylation event distinct 
from the catalytic phosphorylation. However, in the light of the findings discussed above, it 
seems that this additional phosphorylation alone does not determine the location of the 
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ATPase, but the catalytic phosphorylation also affects it. Secondly, mutations that impaire 
the localization or trafficking of WND and MNK are not concentrated on any particular site 
in the protein. They are found in the N-terminal metal-binding sites, (Goodyear et al., 1999; 
Strausak et al., 1999), at, or near the intramembraneous metal binding site, (the CPx motif) 
(Tümer et al., 1999; Petris et al., 2002; Kim et al., 2002), in the nucleotide-binding domain, 
(the HP motif) (Payne et al., 1998), as well as from the C-terminus (mutation A1364V in 
the 7th TM-helix) (Ambrosini & Mercer, 1999) of WND, or MNK.  
Copper-dependent trafficking plays undoubtedly a significant role in the development of 
Wilson disease. However, so far there is little, if any, evidence of a specific mechanism 
which would explain how the mutations would affect trafficking itself. In several cases the 
failure in trafficking seems to be connected to the impaired activity of a mutated ATPase. 
  
5 Functional sites of P1B-ATPases 
5.1 Common mechanism of function 
 
Even though the sequence similarity is generally low among P-type ATPases, the structural 
motifs forming the catalytic center of phosphorylation and dephosphorylation activities are 
well conserved throughout the protein family (Møller et al., 1996; Solioz et Vulpe, 1996; 
Lutsenko & Kaplan, 1995; Axelsen & Palmgren, 1998; Palmgren & Axelsen, 1998). Hence, 
all P-type ATPases are supposed to function by the same catalytic mechanism despite the 
differences of the direction, form and stoichiometry of the transported substances. The 
characteristic features of the individual subfamilies are seen in the other parts of the 
enzyme. Several sequence motifs have been recognized, which are unique for the P1B-
ATPases (Solioz & Vulpe, 1996; Lutsenko & Kaplan, 1995). These include two motifs, the 
HP and the GxGxxG/A, which are found in the N domain, the CxxC in the N-terminus and 
the CPx (x is Cys, His, or Ser) located in the putative sixth TM-helix (see Figure 6). The 
two cysteine motifs form metal-binding sites. These motifs are discussed in the following 
chapters. 
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5.2 Metal-binding sites and substrate specificity 
 
N-terminal metal-binding domains 
Principally, two forms of N-terminal metal-binding motifs exist. The most commonly 
encountered is the CxxC motif. These are parts of metal-binding domains (MBD), that are 
present in one or two copies in prokaryotes, whereas eukaryotic ATPases may have up to 
six copies, like in WND and MNK (Argüello, 2003). Some ATPases have N-terminal 
sequences rich in histidines (Odermatt et al., 1993; Argüello, 2003). These histidine-rich 
sequences exist either alone or together with MBDs (Argüello, 2003).  
The structure of an MBD of several ATPases has been determined (Banci et al., 2002; 
Banci et al., 2001; Gitschier et al., 1998). It resembles closely the bacterial mercury-binding 
protein MerP (Steele & Opella, 1997) and the copper chaperone Atx1 of yeast (Arnesano et 
al., 2001), both of which carry a similar cysteine motif. The data from the crystal structures 
(Wernimont et al., 2000) together with spectroscopic experiments (Ralle et al., 2003) 
demonstrate that the CxxC motif forms a novel metal-binding site where the metal ion is 
linearly coordinated between the cysteines. The presence of only two metal ligands instead 
of three or four normally seen in metalloproteins means that the metal ion is not only bound 
less tightly, but it is also more accessible to other ligands (Ralle et al., 2003; Pufahl et al., 
1997). These properties make the site suitable for transient metal binding, that is, the ion 
could be easily exchanged with other metal-binding sites in soluble metal ion carriers and 
with the translocation site, the CPx motif.  
The role of MBDs has proved to be complex. WND and MNK both have six MBDs, and 
these are not interchangeable (see below). The first four domains have been demonstrated 
to interact with the Atox1 metallochaperone. The metal ion can be exchanged between 
these four MBDs and Atox1 by a simple equilibrium reaction (Huffman & O’Halloran, 
2000; Hamza et al., 1999; Larin et al., 1999). The fifth and sixth domains, on the other 
hand, do not interact with Atox1 (Larin et al., 1999). Instead, they seem to be important for 
copper-dependent trafficking. Trafficking is lost if they are deleted and even if they are 
replaced by any of the first four MBDs (Mercer et al., 2003). At least one of the MBDs has 
to be intact for the ATPase to be functional (Mercer et al., 2003; Forbes et al., 1999). These 
results suggest that MBDs are an integral part of the ion-translocation pathway. However, 
low activity have been observed from MNK with all MBDs mutated (Voskoboinik et al., 
2001; Voskoboinik et al., 1999). This is in agreement with reports from studies with 
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prokaryotic ATPases, in which a deletion or mutagenesis of the N-terminus does not affect 
severely the function of the enzyme (Mitra & Sharma, 2001; Bal et al., 2001; Fan, et al., 
2001; Mandal & Argüello, 2003). Moreover, several P1B-ATPases are known, which do not 
have MBDs at all (Rutherford et al., 1999; Borjigin et al., 1999). It seems that there must be 
an alternative way to provide the translocation site with metal ions.  
The N-terminus of WND has been shown to interact in a copper-dependent manner with the 
catalytic loop carrying the N and the P domain (Tsivkovskii et al., 2001). In the presence of 
copper ions the binding is weaker, whereas in the absence of copper, the N-terminus 
hinders the binding of the nucleotide to its binding site. This suggest that MBDs could also 
have a regulatory role by slowing down the residual ATPase activity when copper is not 
available.  
The most recently solved MBD structure is that of ZntA (Banci et al., 2002). In this 
structure an additional aspartate residue acts as a third ligand for the metal ion bound to the 
CxxC motif. This aspartate is supposed to be responsible for rendering the site to favour 
Zn2+, Cd2+ and Pb2+, which are the biological substrates of ZntA. The basis of the substrate 
specificity of the P1B-ATPases is not known. In principle it could be possible that it is 
determined by the N-terminal metal-binding site. However, a chimeric protein with the N-
terminus from WND fused to the C-terminal part of ZntA does not show any alterations in 
its substrate specificity compared to the wild-type ZntA (Hou et al., 2001). This implies that 
the metal specificity originates from an other site. 
 
CPx motif and the basis of the metal selectivity 
As the N-terminal metal-binding sites do not affect the metal specificity of heavy-metal-
transporting ATPases, it must be involved with the intramembraneous metal-binding site. 
Known as the CPx motif (Solioz & Vulpe, 1996), this site exists in forms of CPC, CPH, 
CPS, SPC and TPC (two proteins are known to carry an APC motif) (Argüello, 2003). 
Several studies have been reported in which one or both of the residues flanking the proline 
have been mutated, and the result has invariably been an inactive ATPase (Forbes & Cox, 
1998; Bissig et al., 2001; Yoshimizu et al., 1998). Clearly, this site has to be intact for an 
ATPase to be functional, consistent with the idea that it is the metal translocation site.  
Interestingly, an ATPase with the SPC motif has been shown to be a Co2+ pump 
(Rutherford et al., 1999), while a CPH motif has been found in a Cu2+ specific ATPase. 
Neither of these cations is a good substrate of an ATPase with the CPC motif. However, the 
CPC variant itself is not associated with a specific metal selectivity, as the group of proteins 
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carrying this motif includes both Cu+-ATPases, like WND and MNK, and Zn2+-ATPases, 
like ZntA (see Table 1). Thus, the CPx motif does not determine the substrate specificity 
alone.  
 
 
Table 1. Variants of the metal-binding motif in the 6th TM-helix and its relation to the 
metal specificity 
 
 
 
Motif 
 
Substrate cations 
 
Remarks 
   
CPC Cu+, Ag+ Most common. Carried by both  
 Zn2+, Cd2+, Pb2+ Cu+- and Zn2+-ATPases 
CPH Cu2+, Cu+, Ag+ Primarily Cu2+-ATPases 
CPS Not known rare 
SPC Co2+  
TPC Not known  
APC Not known rare 
   
 
  
 
A general factor that could play a role in ion selectivity is the helix packing (Mandal et al., 
2003). Heavy metal ions differ significantly in their size as well as in their requirements for 
the geometry of the coordination sphere. While the helix packing may be one factor, the 
size of the ion does not seem to play any role in the selectivity. Cu+-ATPases have been 
shown to transport Ag+ ions in addition to Cu+ ions with ionic radii of 126 and 96 pm 
respectively (Weast, 1979). Similarly ZntA has been demonstrated to transport Zn2+, Cd2+ 
and Pb2+ ions with ionic radii of 74, 97 and 120 pm respectively (Weast, 1979). Both types 
of ATPases are not only able to transport ions that vary widely in size, but also the ionic 
radii overlap significantly between the two groups of the substrate cations. Several residues 
have been recently identified in the seventh and eighth TM-helices, conservation of which 
seems to be connected to the metal specificity (see Table 2) (Argüello et al., 2003).  
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Interestingly there is an aspartate in the eight TM helix, conserved only among Zn2+-
ATPases. In case of the N-terminal metal-binding site, an additional aspartate changed the 
selectivity of the site in favor of Zn2+ (Banci et al., 2002). It is plausible that these residues 
could affect ion selectivity by functioning as additional ligands for the metal ion at the CPC 
site, but this idea remains to be experimentally tested. 
 
 
Table 2. Conserved residues of the 7th and 8th TM-helices in Cu+- and Zn2+-ATPases. The 
numbers refer to WND in Cu+-ATPases and to ZntA in Zn2+-ATPases respectively. 
 
 
 
ATPase type 
 
7th TM-helix 
 
8th TM-helix 
   
Cu+-ATPases N1331Y M1359xxSS 
Zn2+-ATPases K693 D714xG 
 
 
5.3 Nucleotide-binding site – the glycine and HP motifs 
 
The residues forming the nucleotide-binding site in Ca2+- and Na+/K+-ATPases are 
conserved in most P-type ATPases, but none of them are found in P1B-ATPases (III). 
Instead, there are two sequence motifs characteristic only to members of this subfamily. 
Both of these are located in the N domain. The HP motif is present 34-43 residues from the 
phosphorylatable aspartate (Lutsenko & Kaplan, 1995; Solioz & Vulpe, 1996) and a protein 
kinase-like GxGxxG/A motif is found downstream in the same domain (III).   
The HP motif has aroused much interest, as the histidine is the residue most often mutated 
among the Western population of Wilson disease patients (Riordan & Williams, 2001; 
Loudianos et al., 2000). The role of the histidine is ambiguous. In vivo, the H1069Q 
mutation has been shown to reduce the half-life of the protein and prevent trafficking 
(Payne et al., 1998). The mutant has been reported to retain significant ATPase activity in 
vitro and it is also able to complement partially ∆Ccc2 yeast strain (Iida et al., 1998, Payne 
& Gitlin, 1998). Recent studies indicate that mutations of the residue affect ATP binding 
(Tsivkovskii et al., 2003; Voskoboinik et al., 2003a, III). However, the mutants have their  
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Pi phosphorylation also impaired, which suggests that the residue might participate in steps 
of the catalytic cycle other than ATP binding (I; Tsivkovskii et al., 2003) (see also chapter 
2.3 in the results section). 
The GxGxxG motif has been demonstrated to interact with ATP in the nucleotide-binding 
pocket of protein kinases (Zheng et al., 1993). Two first glycines in this motif are invariant, 
whereas the last residue is always small; Gly, Ala, or Ser in protein kinases and Gly, Ala, 
Ser, or Cys in P1B-ATPases (Hanks et al., 1988; III). The possibility that this motif would 
also be functionally similar, and participate in nucleotide binding in P1B-ATPases, has been 
studied in this thesis (III) (see chapters 1 and 2.4 in the results section).  
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Aims of the study 
 
 
 
I) Chracterization of E. coli’s zinc-translocating P-type ATPase ZntA. This 
includes determination of the metal specificity of the ATPase activity and 
phosphorylation reactions.  
II) To investigate whether the ZntA overexpression system could be used for study 
the effects of Wilson disease mutations.  
III) To identify the ATP-binding residues in P1B-ATPases as a part of a major 
question of how ATP drives the catalytic cycle.  
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Materials and methods 
1 Cloning and mutagenesis 
 
ZntA was cloned into pTrcHis vector as described in I. Mutations were introduced by PCR 
method (Cormack, 1995). When possible, silent mutations were also introduced to screen 
rapidly the colonies carrying the desired mutation. Finally, the region of the expression 
plasmid corresponding to the PCR fragment was sequenced to verify the proper genotype. 
 
2 Expression 
 
N-terminally his-tagged ZntA constructs turned out to be unstable; cultures stored on plates 
often had deletions in the plasmid, resulting in poor expression of the ATPase. Therefore 
bacterial cultures harboring the expression plasmid were always started from frozen 
glycerol stocks. The detailed expression protocol is described in I. 
 
3 Preparation of membranes 
 
The preparation of bacterial membranes was carried out as described in I. ZntA was 
observed to be susceptible to proteolysis, and PMSF was used in every step to inhibit 
proteases. SDS-PAGE was used routinely to estimate the expression levels of the mutants. 
In some early experiments the membranes were prepared with buffers at pH 8.0, but in later 
experiments pH 7.5 was used, because it preserves the activity better. 
 
4 ATPase activity measurement 
 
ATPase activity was determined directly on the membranes of ZntA-expressing strain using 
the phosphate analysis method (Lutter et al., 1993) with some modifications (I). To create a  
Cu+ species, 5 mM DTT was added to reaction mixture containing CuSO4.  
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5 Labeling by [33P]ATP and [33P]Pi 
 
ATP phosphorylation 
Phosphorylation of the membrane fraction by [γ-33P] ATP (Amersham Pharmacia) was 
carried out on ice in pH 6.0 as described in I. The reaction was started by adding a solution 
containing ATP and 8 mM MgCl2. The reaction was stopped after 30 s by addition of ice-
cold 10% TCA. The membrane pellets were washed once with ice cold water and once with 
ice-cold 50 mM H3PO4, pH 2.4. The acidic conditions are necessary for the stability of the 
phosphointermediate (Makinose, 1969). In the results section all the data presented is 
corrected for the dilution factor. 
 
Pi phosphorylation 
Phosphorylation by [33P]Pi  was carried out at room temperature. The reaction mixture was 
pipetted as above, but the reaction buffer was 100 mM MES, pH 6.0, 25-40% DMSO when 
metal ions were included; when the heavy metal ions were not present, the reaction mixture 
contained also 0.5 mM EDTA. The reaction was started by adding  40 µCi [33P]Pi and 8 
mM MgCl2 giving a final concentration of Pi of 100 nM. The reaction time was 10-12 min. 
 
Analysis of the phosphointermediates 
The analysis of phosphointermediates by acidic SDS-PAGE was carried out essentially as 
described by Fairbanks and Avruch, 1972, at pH 2.4. The bands were analyzed in the 
phosphoimager. 
 
6 Dephosphorylation 
 
The rate of dephosphorylation of the phosphoenzyme intermediate  was determined in the 
absence of ADP (dephosphorylation via the E2P intermediate) and in the presence of ADP 
(dephosphorylation directly from the E1P form). The membrane fractions were first 
phosphorylated with [γ-33P]ATP as in the phosphorylation assay above. Phosphorylation 
was allowed to proceed for 30 s after which the reaction was stopped with 5 mM EDTA 
with 250 µM ADP or with 5 mM EDTA alone. The protocol is described more in detail in 
II.  
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7 Modelling 
 
Sequence alignment. The alignment in Figure 9 was constructed using ClustalX (Thompson 
et al., 1997). In order to create gap penalties for the program, the known secondary 
structure of sarcoplasmic Ca2+-ATPase and the predicted secondary structure of ZntA (see 
below) were used.  The P-type ATPase sequences used are listed in III.      
 
Secondary structure predictions.  The secondary structure of ZntA was predicted using the 
PHD program (http://www.embl-heidelberg.de/predictprotein/) (Rost, 1996). The input 
consisted of all the heavy metal ATPase sequences listed in III. To test the reliability of the 
prediction program, the secondary structure of Ca2+-ATPase was also analysed using the 
sequences of Na+, K+-ATPases and Ca2+-ATPases (the plasma membrane Ca2+-ATPases 
were not included) as the input.  In general, the secondary structure prediction of Ca2+-
ATPase, carried out without information about the three-dimensional structure, agreed well 
with the secondary structure elements observed in the crystal structure. In particular, all the 
secondary structure elements (see Figure 1) which we proposed to constitute the core of the 
N domain of P-type ATPases were predicted correctly when using only the Ca2+- and Na+, 
K+-ATPase sequences as the input.  
 
Modelling. The coordinates of sarcoplasmic Ca2+-ATPase (PDB entry 1IWO), describing 
the Ca2+-ATPase structure in the E2 state at a 3.1 Å resolution (Toyoshima & Nomura, 
2002), were obtained from the Protein Data Bank (PDB). The correspondence between 
Ca2+-ATPase and ZntA was established using secondary structure prediction and sequence 
alignment (Figure 1). The loop ranging from G503 to V510 in ZntA was positioned similarly 
with the Ca2+-ATPase loop between residues L485 and S495. This loop comprises residues 
F487, R489 and K492, suggested to interact with ATP in Ca2+-ATPase. The conformation of 
the segment G503SGIEAQV of ZntA was then modelled using the structure of the glycine 
loop (G50TGSFGRV) of cAMP-dependent kinase (cAPK, PDB entry 1ATP) as the 
template. The conformations of other loops connecting the conserved secondary structure 
elements were taken from PDB using Insight II loop search utility. 
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Results 
1 Modelling the N domain of ZntA 
1.1 Sequence alignment of P-type ATPases 
 
The crystal structures of Ca2+-ATPase (Toyoshima et al., 2000; Toyoshima & Nomura, 
2000) provided a possibility to use homology modelling to support the mutagenesis studies. 
P-type ATPases in general share a low sequence similarity, which is typically in a range of 
15-25%. The homology is mainly seen in the conserved sequence motifs, which form the 
functionally important sites. These sites can be used to align different P-type ATPase 
sequences. The M and N domains, however, do not contain any sequence motifs common 
to all P-type ATPases. The latter domain in P1B-ATPases contains several residues not 
conserved in other P-type ATPases. Mutations in many of these P1B-ATPase-specific 
residues result in Wilson disease.  
The N domain of Ca2+-ATPase comprises the residues N359 – P602, whereas in ZntA the 
domain is significantly smaller, ranging from G444 to T560 (Figure 9). The identity between 
the sequences is about 13%. The alignment was made using the secondary structure 
information of the two proteins (III, Figure 9). A comparison of the Ca2+-ATPase 
secondary structure and the predicted secondary structure of ZntA suggested that the 
elements forming the core of the N domain in Ca2+-ATPase were preserved also in ZntA. 
The parts missing from ZntA were largely loops which folded on the surface of the domain 
in Ca2+-ATPase. The core was defined on the basis of the temperature factors of the E1 
structure (see Figure 9). The alignment with a number of different P-type ATPases 
demonstrates that the core is conserved throughout the protein family although many 
insertions and deletions are seen in this area in individual subfamilies. 
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Figure 9. An alignment of N-domain sequences of P1-, P2- and P3-type ATPases. The 
accession number of each sequence is on the left.  The sequences are: P04191 (rabbit 
sarcoplasmic Ca2+-ATPase), AAB50172 (human H+,K+-ATPase), AAC05260 (pig Na+,K+-
ATPase), AAA81005 (rat plasma membrane Ca2+-ATPase), B39083 (Salmonella 
typhimurium Mg2+-ATPase), AAA33563 (Neurospora crassa H+-ATPase), P20431 
(Arabidopsis thaliana H+-ATPase), Q04656 (Menkes disease protein, human Cu+-ATPase), 
P35670 (Wilson disease protein, human Cu+-ATPase), JC5573 (Caenorhabditis elegans 
Cu+-ATPase), P38995 (Saccharomyces cerevisiae Cu+-ATPase), P78245 (Escherichia coli 
Cu+-ATPase), P20021(Staphylococcus aureus Zn2+-ATPase), P37617 (ZntA, Escherichia 
coli Zn2+-ATPase). The secondary structure of the rabbit sarcoplasmic Ca2+-ATPase, based 
on the crystal structure 1IWO, is indicated with arrows and helix symbols above the 
 49 
sequences. The predicted secondary structure of ZntA is shown beneath the sequences. The 
residues in the Ca2+-ATPase sequence shown in white have been proposed to interact with 
bound ATP. The bottom line indicates the magnitude of the temperature factor for each 
amino acid residue in the Ca2+-ATPase crystal structure 1EUL [1]:  thick line, B < 35 Å2; 
thin line 35 Å2 < B < 55 Å2; no line, B  > 55 Å2. The segments forming the core secondary 
structure elements are highlighted with dark grey.  The well-conserved residues are in light 
grey. The ATP-binding loop of Ca2+-ATPase is marked by a black box, which is used to 
indicate the HP and glycine motifs in the P1B-ATPases. ZntA mutants studied are marked 
with asterisks. The alignment is modified from III. 
 
1.2 The molecular model of the N domain of ZntA 
  
The N domain has a novel fold (Stokes & Green, 2003), preventing the usage of proteins 
other than P-type ATPases in the modelling. As already mentioned, the ATP-binding 
residues of the P2-ATPases are not conserved in the P1B-ATPases. On the other hand, 
proteins of this subfamily possess two sequence motifs, the HP and GxGxxG/A, which are 
missing in other P-type ATPases. The major question in the modelling was, whether these 
two sites could be modelled as part of the putative nucleotide-binding site. 
The model of the N domain of ZntA (III) and the structure of the N domain of Ca2+-
ATPase are compared in figure 10. In general, the N domain of ZntA is composed of a β-
sheet surrounded by three α-helices. In Ca2+-ATPase the ATP-binding cleft is formed 
mainly by the helix α2, strand β11 and a loop containing residues L485-S495. In the sequence 
alignment the first two elements are conserved in ZntA (helix α2 and strand β4), but there 
is no clear counterpart for the loop L485-S495. However, the GxGxxG/A motif is found in 
this region and to preserve the overall form of the ATP-binding site, the GxGxxG/A was 
modelled in place of the loop in Ca2+-ATPase. 
According to the model, the HP dipeptide is a part of the loop V469EQGATH475P, which 
connects the N domain helices α1 and α2. H475 is predicted to be at the N-terminus of the 
helix α2. In the alignment this residue corresponds to E439 in Ca2+-ATPase and D443 in 
Na+/K+-ATPase, the latter of which is suggested to be involved in ATP binding (Patchornik 
et al., 2000; Goldshleger & Karlish, 1999). In Ca2+-ATPase two residues nearby, T441 and 
E442, are likely to play role in ATP binding (Clausen et al., 2003; Hua et al., 2002b). It is 
also interesting that the in the E2 structure E439 is seen to be very close to the A domain: it is 
roughly in the distance of 4 Å from S186, or 3 Å from R174. Hence, it is possible that H475 in 
ZntA interacts with the A domain in the E2 state (see the discussion). 
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Figure 10. Comparison of the molecular model of the N domain of ZntA and the structure 
of the Ca2+-ATPase N domain (PDB entry 1IWO). The blue colour indicates the areas 
constituting the conserved core of the domain. The amino acid residues we have mutated in 
this work are displayed with orange colour, which is also used to indicate the residues 
involved in ATP binding in Ca2+-ATPase. The Wilson disease mutation analogues are 
underlined. The G503 loop in ZntA, modelled using the glycine loop of cAPK as a template, 
and the Ca2+-ATPase loop carrying three ATP-binding residues (F487, R489 and K492) are 
displayed in green.  
An ATP molecule coloured red, taken from the crystal structure of cAPK (PDB entry 
1ATP), is shown to provide a molecular scale. The approximate locations of the P and A 
domains are indicated. The figure is modified from III. 
 
 
The GxGxxG/A motif is found in a long stretch of residues between the helix α2 and the 
strand β4 (β11 in Ca2+-ATPase). Virtually no sequence homology is found between ZntA 
and Ca2+-ATPase in this region. In Ca2+-ATPase, a part of this sequence folds into a loop 
that carries the ATP-contacting residues F487, R489 and K492. The glycine motif of ZntA, 
(G503SGIEAQV510) resembles the ATP-binding loop of cAPK (G50TGSFGRV57). 
Assuming that the overall shape of the ATP-binding site of the P1B-ATPases resembles that 
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of other P-type ATPases, the glycine loop might replace the ATP-binding loop of the Ca2+-
ATPase. Hence, the glycine loop of ZntA was modelled using the cAPK glycine loop 
structure (Zheng et al., 1993) as a template and it was placed in an analogous orientation to 
that of Ca2+-ATPase loop L485-S495. In silico, this substitution can be implemented without 
affecting the core structure of the domain. However, the direction of the peptide chain is 
reversed in the ZntA model compared to the L485-S495 loop in Ca2+-ATPase structure. In 
conclusion, a model for ZntA N domain can be constructed, in which the HP and 
GxGxxG/A motifs are placed in the putative ATP-binding site, while preserving the core 
structure of the domain. 
The model predicts two residues, C518 and E470, which do not belong to the two motifs, to 
be also found in the nucleotide binding site. The former is situated on the edge of the 
nucleotide-binding cleft, whereas the latter is found at the bottom of the binding site. Two 
Wilson disease mutations, E470A and E470K, have been found to affect E470 (Shah et al., 
1997; Figus et al., 1995). The mutants C518P and E470A have been reported in 
publications I and III (see Table 3). Both mutations result in a significant ATP-binding 
defect, namely impaired phosphorylation by  ATP and resistance to ATP-driven E2-E1 state 
conversion (III). These results are consistent with the idea that the residues are close to the 
ATP-binding site.   
 
Table 3. Mutants C518P and E470A.  
Mutant Expression (%) ATPase  
activity (%)     
ATP phosphorylation (%) 
60 nM    58 µM 
Pi Phosphorylation (%) 
Pi     Pi+ATP  Pi+Zn 
 
WT 
E470A 
 
100 
184 
 
100           
 17            
 
 14            100           
 0.1            5.2 
 
100       12        16 
 86        79        17 
C518P 115  88  1.2            67  65        32        12 
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2 Introducing Wilson disease mutations into ZntA 
2.1 ZntA as a model for WND 
 
Wilson disease mutations are found in all regions of the WND sequence, but many of them 
affect residues conserved among P1B-ATPases. This allows using ZntA to study the 
function of the residues mutated in Wilson disease. ZntA is an ideal protein for studying the 
function of an P1B-ATPase, as it does not contain multiple metal-binding domains, 
additional phosphorylation sites, or sugar residues that would complicate the experiments 
and interpretation of the results. While the bacterial system cannot be used to study 
trafficking, it does have some advantages in comparison to the yeast system. Unlike in 
eukaryotes, in which the ATPase localizes to the TGN membranes, in bacteria it is found at 
the plasma membrane, being readily accessible for the experimentation. Overexpression of 
ZntA allows direct measurements of ATPase activities and phosphorylation of mutant 
proteins in the membranes. 
 
2.2 Conformational mutants G444V and P634L  
 
One functionally interesting class of mutants is composed of those affecting the 
conformational stability of the ATPase. In this work two mutants were found, displaying 
characteristical features of a conformational mutant: G444V (III) and P634L (II), 
corresponding to Wilson disease mutations G1035V and P1274L reported in Nanji et al., 
1997 and in Loudianos et al., 1996. G444 is located at the strain connecting the N and P 
domains. Comparison of the E1 and E2 structures reveals that this sequence stretch 
undergoes structural changes during the state conversion. P634 is situated in the 
GDGxNDxP motif at the P domain. This motif was originally thought to function as a 
hinge (MacLennan et al., 1985; Taylor & Green 1989). However, when the crystal 
structures of Ca2+-ATPase were reported, it turned out that the motif remains immobile in 
respect to the rest of the P domain, when the domain itself moves during the catalytic cycle. 
However, in the E2 state the A domain packs together with the P domain and P709 
(corresponding to P634 in ZntA) is at the interface of the two domains.  
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Expression and ATPase activity 
Both G444V and P634L displayed a wt-like expression (Table 4). The G444V mutant 
retained a moderate ATPase activity of 32%, whereas the mutation P634L resulted in a 
severe reduction of activity, preserving only 7% of the wt activity. 
 
Table 4. Expression and ATPase activity of mutants of putative communication pathways. 
The numbers refer to the percentage compared to the wt activity. The ATP concentration 
used was 4 mM. 
 
 
Mutant Expression (%) ATPase activity (%) 
 
G444V 
  
92 
 
32 
P634L 105  7 
 
 
ATP and Pi phosphorylation 
The mutant G444V was able to autophosphorylate to a level roughly corresponding to its 
ATPase activity level (Figure 11a). Surprisingly, the mutant P634L displayed normal ATP 
phosphorylation practically indistinguishable from the wt.  
In the Pi phosphorylation assay the mutants G444V and P634L behaved exactly in the 
opposite way in respect to the ATP phosphorylation. G444V was hyperphosphorylated to a 
level three times as high as the wt phosphorylation (Figure 11b). In contrast, the 
phosphorylation of the mutant P634L was barely visible.  
The nature of the Pi phosphorylation of mutant G444V was investigated further by 
measuring the phosphorylation level in the presence of ATP and zinc. Both of these 
substances stabilize the E1 state and therefore reduce the Pi phosphorylation. Interestingly, 
the mutant retained normal zinc sensitivity of the Pi phosphorylation, whereas a clearly 
reduced ATP sensitivity was observed (Figure 11c). 
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Figure 11. Phosphorylation of the mutants by ATP (A) and Pi (B). The ATP concentration 
was 2.5 µM with P634L mutant, whereas a 5 µM ATP was used with G444V. C) Pi 
phosphorylation of the wt and mutant G444V in the absence and presence of 1 mM ATP or 
100 µM Zn2+. 
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Dephosphorylation 
Both mutants displayed abnormal dephosphorylation kinetics (Figure 12). In overall, the 
mutants G444V and P634L dephosphorylated at a similar rates, but G444V seems to have 
biphasic kinetics with a slow phase during the first five seconds, while the P634L mutant 
shows a wt-like dephosphorylation with only one phase.  
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Figure 12. Dephosphorylation of the mutants. 
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Figure 13. Dephosphorylation of the mutants in the presence of 250 µM ADP (A). 
Dephosphorylation of the wt and P634L in the presence of 25 µM ADP (B). 
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In the presence of ADP, dephosphorylation occurs from the E1~P to the E1 state. 
Dephosphorylation rate of mutant G444V is slowed down also in this assay (Figure 13A). 
In contrast, P634L has a very fast dephosphorylation rate, which could be verified  to be 
faster than that of the wt by using a lower ADP concentration (Figure 13B). 
 
2.3 H475Q – a unique multirole residue 
 
The HP motif is found 34-43 residues from the DKTG aspartate in P1B-ATPases. The 
histidine-475 is the most common Wilson disease mutation site in the Western population 
(Riordan & Williams, 2001; Loudianos et al., 2000). The WND mutant H1069Q displays 
abnormal trafficking and reduced ATP affinity (Payne et al., 1998; Tsivkovskii et al., 2003; 
Voskoboinik et al., 2003a). In this work the motif was studied by characterizing mutants 
carrying the analogous mutation H475Q (I; II; III) as well as substitutions H475A, H475L, 
H475S and H475D (III). 
 
Table 5. Expression and ATPase activity of H475 mutants. The activity was assayed at 4 
mM ATP. The numbers refer to the percentage of the wt activity. 
 
 
Mutant Expression (%) ATPase activity (%) 
4 mM        0.45 mM 
 
WT 
H475Q 
 
100 
106 
 
100           69 
  43            6 
H475A 115    8 
H475L 
H475S 
H475D 
110 
139 
168 
   5 
  16 
   1 
 
 
Expression and ATPase activity of the H475 mutants 
All mutants are expressed at a little higher level than the wt (Table 5). Artificially 
expressed ATPase is likely to be toxic to the cell and probably for this reason mutants with 
lower ATPase activity are tolerated better.  
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At a 4 mM ATP concentration, which corresponds to cellular conditions, the H475Q mutant 
has substantial ATPase activity of ~ 40% of the wt level. Other substitutions result in a 
more severe reduction of activity. Aspartate is an especially unfavorable replacement 
leading to an almost complete loss of activity. 
The activity of the H475Q mutant depends strongly on the ATP concentration. Reducing 
the concentration to 0.45 mM, results in the ATPase activity of the H475Q mutant to drop 
7-fold, whereas the wt enzyme was observed to slow down only by 30%. 
 
ATP phosphorylation of the H475 mutants 
A range of ATP concentrations from 60 nM to 58 µM was used in the ATP phosphorylation 
assay (Figure 14). At submicromolar concentrations the histidine mutants are 
phosphorylated to a level of less than 5% of that of the wt. All mutants show improved 
phosphorylation at a 58 µM ATP concentration. The phosphorylation of H475Q indicates 
that the Km for ATP of the mutant is two orders of magnitude higher  than that of the wt. 
This result agrees with the previous findings with corresponding MNK mutant 1086Q 
showing similarly roughly a hundred fold increase of Km for ATP (Voskoboinik et al., 
2003a). 
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Figure 14. ATP phosphorylation of H475 mutants. 
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Pi phoshorylation of the H475 mutants 
Keeping in mind that the N domain does not participate in Pi phosphorylation, one would 
expect that the mutations of H475 do not affect this event. Surprisingly, none of the mutants 
display normal Pi phosphorylation (Figure 15). Moreover, the level of phosphorylation does 
not reflect the ATPase activity or the ATP phosphorylation of the mutants. Unlike in the 
previous assays, in this experiment the H475Q substitution is not the most favorable one 
(III). The highest phosphorylation levels are shown by the mutants having the smallest 
sidechains: H475A and H475S. There seems to be a correlation between Pi phosphorylation 
and the size of the side chain. The only exception is the mutant H475D, which has the 
weakest phosphorylation despite its small size. A likely explanation is that the aspartate is 
the only substituent carrying a charge. It might be that charged residues are not tolerated in 
this position, or alternatively, that the negatively charged residue is an especially 
unfavorable substitution, because the histidine might carry an opposite charge. 
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Figure 15. Pi phosphorylation of the H475 mutants. The phosphorylation was also assayed 
in the presence of 1 mM ATP (black bars) and 100 µM Zn2+ (grey bars). 
 
 
Pi phosphorylation is sensitive both to the presence of substrate cations and to the presence 
of ATP. However, the mutants are less sensitive to these substances than the wt, especially 
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mutant H475S. In every H475 mutant, ATP and Zn2+ have a roughly equal effect on Pi 
phosphorylation, regardless of how sensitive the particular mutant is to these substances. 
Hence, unlike in the previous assays, no purely ATP-dependent mutational phenomena are 
observed in this experiment. 
 
2.4 Mutants G503S, G505R and A508F in the putative ATP-binding loop 
 
The N domain of P1B-ATPases carries a protein kinase-like GxGxxG/A motif, which in the 
case of ZntA is G503xxGxA, whereas a G1099xxGxC sequence is found in WND. Several 
Wilson disease mutations target the conserved residues of the motif: G1099S, G1101R and 
C1104F (Loudianos et al., 1999; Loudianos et al., 2000). Here, the analogous ZntA mutants 
G503S, G505R and A508F, were characterized (III). Glycine motifs tend to be found at 
nucleotide-binding sites (Saraste et al., 1990; Bossemeyer, 1994; Kinoshita et al., 1999; 
Vetter & Wittinghofer, 1999). However, they vary not only in their exact primary structure, 
but also in the way they interact with the nucleotide (Bossemeyer, 1994; Vetter & 
Wittinghofer, 1999). In the modelling section (see chapter 1.2)  the motif was shown in 
principle to be able to reach the putative nucleotide binding site. The biochemical evidence 
is discussed here. 
 
Expression and ATPase activities of the glycine loop mutants  
The expression of the mutants was slightly increased compared to the wt, excluding 
G505R, which was expressed at a little lower level. All three mutants showed reduced 
ATPase activities (Table 6). 
Surprisingly, at 4 mM ATP the mutation G505R has a considerable activity (60% of the wt 
level), despite the fact that the small glycine was replaced with a very large arginine, which 
also introduces a charge. However, a clearly impaired ATPase activity was observed when 
the ATP concentration was lowered to 0.45 mM. When the residue is substituted by 
glutamate, i.e., when the opposite charge is introduced, a severe drop in ATPase activity is 
evident even at 4 mM ATP. 
 
 
 60 
Table 6. Expression and activity of the glycine motif mutants. The numbers refer to the 
percentage compared to the wt activity. 
 
Mutant Expression (%) ATPase activity (%) 
4 mM       0.45 mM 
 
G503S 
 
133 
 
22 
G505R  90 60             13 
A508F 
G503D 
G505E 
116 
136 
159 
11 
22 
11 
 
  
ATP phosphorylation of the glycine loop mutants  
The overall ATPase activities of the mutants reflect their abilities to undergo ATP-
dependent phosphorylation (Figure 16). However, at 58 µM ATP, which was the highest 
concentration used in the measurement, the phosphorylation defect of the G503 and G505 
mutants becomes much less severe than would be expected on the basis of their overall 
activities. This implies that ATP phosphorylation is not alone causing impaired activity. 
The mutant A508F remains poorly phosphorylated in the concentration range used. 
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Figure 16. ATP phoshorylation of the mutants of the glycine motif. 
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Pi phosphorylation of the G-loop mutants 
The mutations G503D, G505E, and G505R do not affect the Pi phosphorylation reaction 
(Figure 17). Instead, the mutant G503S is hyperphosphorylated, whereas mutant A508F is 
hypophosphorylated in this assay (III). It seems that the G503S mutant favors the E2 state. 
The mutant A508F seems to have an overall phosphorylation defect, because it remains 
poorly phosphorylated regardless of the phosphate donor used. 
When Pi phosphorylation is carried out in the presence of 1 mM ATP, none of the mutants 
display a wt-like behaviour. All of them phosphorylate better than the wt when ATP is 
present. In contrast, they respond normally to the presence of zinc. The only exception is 
the mutant G503S, which is hyperphosphorylated in all conditions tested. However, while 
the phosphorylation level was approximately 1.5 and 2 times higher in the absence and 
presence of zinc, respectively, more than a six-fold increase was observed in the presence 
of ATP. This indicates that ATP binding is affected also in the G503S mutant. 
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Figure 17. Pi phosphorylation of the mutants of the glycine motif. The phosphorylation was 
also assayed in the presence of 1 mM ATP (black bars) and 100 µM Zn2+ (grey bars). 
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3 Characterization of the metal-binding sites of ZntA 
3.1 Metal specificity of ZntA 
 
Metal specificity of the ATPase activity 
Initially, ZntA was found in a mutant strain that was reported to be sensitive to Zn2+, Cd2+ 
and Co2+ salts (Beard et al., 1997). ZntA-mediated 65Zn2+ and 109Cd2+ transport was 
demonstrated in the second study, but the ZntA knock-out strain did not show any changes 
in the rate of growth in Co2+ containing media (Rensing et al., 1997). In the third study, a 
strain with a disrupted ZntA gene was observed to be sensitive also to Pb2+ salts. In 
addition, Pb2+ was shown to activate ZntA. The actual ZntA-mediated transport of Pb2+ was 
not demonstrated (Rensing et al., 1998).  
In this work, the metal specificity of ZntA was studied by measuring the ATPase activity of 
E. coli membranes in the presence and absence of several heavy metals (I). The ATPase 
can also be purified and reconstituted, but it retains activity only if a substrate metal is 
present during the purification, complicating the characterization of the metal selectivity of 
the purified protein (results not shown).  
Initial measurements failed to detect any significant induction of ATPase activity in the 
membranes incubated with Ni2+, Mn2+, Co2+, Hg2+ and Cu2+. Clearly enhanced ATPase 
activities were observed in the presence of Zn2+, Cd2+, Pb2+ and Ag+ (I, Figure 6A). The 
Ag+-dependent activity turned out to be an artefact caused by the precipitation of Ag+ 
(results not shown). 
 
Metal specificity of the [33P]-ATP phosphorylation 
Metal specificity was tested also with the ATP phosphorylation assay (I). The experiment 
confirmed the results of the ATPase activity assay, namely that ZntA is active in the 
presence of Zn2+, Cd2+ and Pb2+ (I, Figure 6B). Interestingly, the phosphorylation levels in 
the presence of these three metals did not correspond to ATPase activity. Cd2+ is the 
weakest inducer of ATPase activity, but it is able to induce the highest level of ATP 
phosphorylation. 
Surprisingly, also Cu2+ stimulated significant ATP phosphorylation, despite the fact that it 
could not induce measurable ATPase activity. When the metal was reduced to Cu+ by 
adding 5 mM DTT to the solution, phosphorylation disappeared. Weak phosphorylation 
was induced also by Ni2+. These results have been reproduced by Hou and Mitra, 2003. In 
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addition they discovered that also Co2+ induced weak ATP phosphorylation, roughly at the 
same level than Ni2+. Currently there is no evidence of the Cu2+, Ni2+ and Co2+ ions to be 
actually translocated by ZntA.  
 
3.2 Mutations of the N-terminal metal-binding domain 
 
Role of the N-terminal metal-binding domain 
The function of the N-terminal metal-binding domain remains unclear. Human ATPases 
seem to possess them to capture the substrate metal from the chaperone as well as to 
regulate copper-dependent trafficking. There is no trafficking in bacteria and so far no 
chaperones for Zn2+ have been found. Moreover, ZntA remains functional both in vivo and 
in vitro if the N-terminus is deleted (Mitra & Sharma, 2001). 
In this work the function of the N-terminal metal-binding site was studied by characterizing 
the properties of the two mutants, in which the C59AAC site was disrupted by mutating it to 
S59AAS (named SAAS) and A59AAA (named AAAA). The latter mutant was produced to 
ensure that the metal-binding site is non-functional (see chapter 3.3). These results have not 
been previously published. 
 
Expression and ATPase activity of SAAS and AAAA mutants 
Both mutant proteins were markedly overexpressed, being roughly 2-3 times as abundant as 
the wt (Table 7). The ATPase activity assay showed that the mutations reduce the Vmax of 
the enzyme approximately by 50%. No change in Km was observed (Figure 20). These 
results agree with those reported in Mandal & Argüello, 2003.  
 
Table 7. Expression and activity of the mutants of the N-terminal metal-binding site. The 
numbers refer to the percentage compared to the wt activity. 
 
 
Mutant Expression (%) ATPase activity (%) 
 
SAAS 
 
327 
 
42 
AAAA 259 50 
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Figure 20. Zinc-dependence of the ATPase activity. 
 
ATP and Pi phosphorylation 
The mutants were phosphorylated almost normally by ATP in the range of 0.1-10 µM Zn2+ 
(Figure 21). This excludes the proposed role of MBDs as enhancers of the ATPase activity 
at low metal concentrations (Voskoboinik et al., 2001). 
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Figure 21. ATP phosphorylation of mutants of N-terminal metal-binding site. 
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In the presence of Pi, the mutants SAAS and AAAA were phosphorylated to the level of  
40% and 60% of the wt level respectively (Figure 22A). This corresponds roughly to their 
ATPase activities. In the presence of Zn2+ the mutants behave peculiarly (Figure 22B). The 
Pi phosphorylation of both mutants show increased sensitivity to zinc at 2 µM concentration 
in comparison to the wt. Between 2 and 200 µM phosphorylation of the mutants remains 
relatively unchanged. In contrast, the Pi phosphorylation of the wt drops roughly by 75%. 
At millimolar zinc concentrations there is no significant difference between the mutants and 
the wt.  
 
A) 
0
20
40
60
80
100
120
Wt SAAS AAAA
re
la
tiv
e 
ph
os
ph
or
yla
tio
n
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
2,5 3 3,5 4 4,5 5 5,5 6
-log [Zn]
re
la
tiv
e 
ph
os
ph
or
yla
tio
n AAAA
SAAS
Wt
B) 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. A) Pi phosphorylation of mutants of N-terminal metal-binding site. B) Zinc 
sensitivity of Pi phosphorylation. 
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3.3 Translocation site – mutant SPS  
 
Disease mutations have been found to affect the CPx motif both in Wilson disease (C985Y, 
Haas et al., 1999) and in Menkes disease (C1000R, Tümer et al., 1999). Consistently, 
several studies have demonstrated that it is essential for the ATPase function that the site is 
intact (Forbes & Cox, 1998; Bissig et al., 2001; Yoshimizu et al., 1998). ZntA carries a 
C392PC sequence, which is also found in WND. Despite having identical motifs in their 
translocation sites, the two ATPases have different substrate specificities. In this work the 
function of the site was studied by mutating the cysteines to create an S392PS motif (named 
as SPS mutant). These results have not been previously published.  
 
Expression and activity 
The mutant was clearly overexpressed being approximately twice (230% of the wt 
expression) as abundant as the wt in the membranes. A very low level of activity of 2% was 
measured for the SPS mutant, but this value is close to the detection limit of the 
colorimetric method and the standard error of the measurement was 3%. 
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Figure 23. ATP phosphorylation of the SPS mutant. Phosphorylation level of the wt is 100 
at 10 µM Zn2+. 
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Phosphorylation by ATP and Pi 
Consistently with possible ATPase activity, the SPS mutant displays Zn2+-dependent ATP 
phosphorylation (Figure 23). This phosphorylation is much weaker than that of the wt, but 
it can be detected in a zinc concentration as low as 0.1 µM. The maximum is reached at 100 
µM Zn2+. If the CPC site is mutated to APA, phosphorylation is completely abolished 
(results not shown). 
 
In contrast to the Ca2+-ATPase mutants with substitutions in Ca2+-binding residues (Clarke 
et al., 1989), the SPS mutant was extremely poorly phosphorylated by Pi. Even more 
surprising is that, unlike the wt, the SPS mutant is maximally phosphorylated in the 
presence of a micromolar concentration of Zn2+, and not in the absence of Zn2+. This 
phenotype has not been observed in any other ZntA mutant studied. Normally, zinc reduces 
Pi phosphorylation because it stabilizes the E1 state. 
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Figure 24. The zinc sensitivity of the relative Pi phosphorylation of the wt and SPS. The 
value 100 refers to the Pi phosphorylation of a strain in the absence of zinc. 
 
 
 
 68 
Discussion 
 
1 Modelling of the N domain of ZntA 
 
The modelling of ZntA was carried out assuming that the N domain has a common core 
structure, which is conserved in all P-type ATPases. In general the N domains of ZntA and 
Ca2+-ATPase share an identity of 13%, but in the region, which contains the glycine motif 
there is practically no sequence similarity at all. The glycine motif resembles that found in 
protein kinases, which is why the cAPK structure (Zheng et al., 1993) was used as a 
template instead of Ca2+-ATPase to model this particular region. As the glycine-rich loops 
are likely to be evolved by convergent evolution (Via et al., 2000), the two motifs found in 
ZntA and cAPK are not necessarily identical structurally, but the secondary structure 
predictions for the two proteins are very similar in this region (results not shown).  
Moreover, nothing is known about the location and orientation of the glycine motif loop in 
the N domain. However, the modelling demonstrates that it is possible to construct the 
model in a way that brings the HP and G503xGxxG/A motifs close to the putative ATP-
binding site together with E470 and C518 (see Table 3), all of which are experimentally 
shown to be likely participating in forming the ATP-binding site, without breaking the 
common core structure of the N domain.   
The N domain of WND has been modelled by Efremov et al., 2004. While the alignment 
made in this work differs partly from the one in Figure 9, the region containing the residue 
E470 is aligned similarly. This model was tested by docking an ATP molecule in the 
putative binding site. While in their model the corresponding residue E1064 points away 
from the nucleotide, it can adopt a conformation where it can interact with the NH2 group 
of the nucleotide (Efremov et al., 2004). Replacing the glutamate with alanine renders the 
ATPase almost insensitive to ATP, when phosphorylated by Pi. This implies that E470 has a 
strong contribution in nucleotide binding, which is consistent with both models. 
 
2 Conformational mutants G444V and P634L 
 
The mutants G444V and P634L are classified as conformational mutants on the basis of 
their phosphorylation properties. The mutant G444V prefers the E2 state, observed as  
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increased Pi phosphorylation. In accordance with this observation, ATP is less capable of 
facilitating the enzyme to adopt the E1 state. However, in the presence of zinc the enzyme 
behaves similarly to the wt showing only a low level of Pi phosphorylation. While the 
mutation shifts the conformational balance towards the E2 state, it does not prevent the E2-
E1 transition per se, but seems specifically to hinder the ATP-driven state conversion. 
The mutant P634L is also  a conformational mutant, but unlike G444V, it favors the E1 
state. The mutant displays a very low ATPase activity despite the normal ATP 
phosphorylation. On the other hand, Pi phosphorylation is severely affected. Previous 
studies with the Ca2+-ATPase mutant P709A did not reveal any major changes in the 
function (Vilsen et al., 1991). However, the E2 structure reveals that the residue is situated 
on the surface that contacts the A domain in this conformation. Hence, it is likely that the 
different results are due to the difference in size between  the two side chains. The most 
probable interpretation is that the mutation P634L hinders the interaction of the A and P 
domains impairing the formation of the E2 state. Interestingly, the N domain is able to 
associate normally with the P domain, judged by the unaffected ATP phosphorylation. 
 
3 Histidine (H475) mutants of the HP motif 
 
The histidine-475 is strictly conserved among P1B-ATPases and mutations of this residue 
result in multiple effects. First of all, they have a significant negative impact on ATP 
phosphorylation. The defect is partially compensated for by higher ATP concentrations 
suggesting that the mutations influence ATP binding. Consistently, ATPase activity shows 
also a strong dependence on ATP concentration.  
Glutamine is able to adopt a conformation where the amide nitrogen is in a similar position 
in comparison to the histidine ε2 nitrogen. The fact that glutamine is a relatively good 
substitute for the histidine compared with the other amino acids tested suggests that the side 
chain nitrogen might play a functional role. On the basis of the sequence alignment, the HP 
motif is located at the N-terminus of the N domain helix α2. This area has been shown to 
be close to the Mg2+ ion at the E2 state of the cycle (Hua et al., 2002b; Patchornik et al., 
2000; Goldshleger et Karlish 1999). The residues D443 and T441, in the Na+/K+- and Ca2+-
ATPases respectively, have been suggested to be coordinating the Mg2+ ion. A His is rarely 
encountered as a Mg2+ ligand, but a few examples are known. MurD ligase from E. coli has 
been crystallized with an ADP molecule and Mg2+ (PDB entry 2AUG; Bertrand et al., 
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1999). Mg2+ is seen to be coordinated by H183. Fitting a γ-phosphate to the bound ADP 
would bring the phosphate close to the Mg2+ ion (Bertrand et al., 1999). At this point it can 
be only speculated how H475 interacts with an ATP molecule, but having an analogous role 
to  H183 of MurD in Mg2+ binding seems to be a possibility. 
In addition to ATP phosphorylation, Pi phosphorylation is also severely impaired, which 
cannot be explained by an ATP binding defect. The WND mutant H1069C has been 
reported to display reduced ATP sensitivity in the Pi phosphorylation assay (Tsivkovskii et 
al., 2003). Similar behaviour was observed with some H475 mutants, especially with H475S. 
This was considered as evidence for a nucleotide binding defect. However, this conclusion 
is complicated by the fact that Pi phosphorylation of the mutants H1069C and H475S is 
also clearly less sensitive to substrate cations. As a conclusion, no clear nucleotide related 
effects are seen in the Pi phosphorylation assay. The observation that the Pi phosphorylation 
defect is related to the size of a side chain suggests that sterical factors are likely to play a 
role here. Indeed, according to the molecular model of the N domain H475 is an equivalent 
of E439 in Ca2+-ATPase, which is located at the interface of N and A domains in the E2 
structure (Toyoshima et Nomura, 2002).  
ATP phosphorylation takes place when the enzyme is in the E1 state, whereas Pi 
phosphorylation occurs only when the enzyme resides in the E2 conformation. The data 
suggest that H475 participates in ATP binding during the phosphorylation step, while there 
is little support for H475 to have a significant role in the nucleotide binding during the E2-E1 
state transition. 
 
4 Glycine motif mutants 
 
All mutants of the glycine motif display non-wt behaviour in the experiments in which ATP 
is used. The mutants G505R, G503D and G505E have completely normal Pi 
phosphorylation in the absence and the presence of substrate cations. Still, all of them 
display diminished ATPase activity and ATP phosphorylation. Their Pi phosphorylation is 
less affected by 1 mM ATP compared to the wt. The mutants G503S and A508F display not 
only impaired ATPase activity and ATP phosphorylation, but also abnormal Pi 
phosphorylation. This suggests that they have other defects in addition to ATP binding. The 
mutation G503S is likely to affect the conformational equilibrium favoring the E2 state, 
whereas A508F might hinder the enzyme to adopt the E2 conformation. 
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The mutation G505R results in a surprisingly mild phenotype. At 4 mM ATP there is only  
a small reduction of ATPase activity, while ATP phosphorylation is normal. However, its 
Pi phosphorylation in the presence of 1 mM ATP is higher than that of the wt, suggesting 
an ATP-binding defect. Consistently, ATPase activity is much more severely affected at a 
lower ATP concentration. In conclusion, all mutations in the glycine motif studied interfere 
with ATP binding. 
 
5 Metal-binding sites of ZntA 
5.1 Metal specificity of ZntA 
 
The metal specificity of ZntA was determined by measuring the ATPase activity and ATP 
phosphorylation on the membranes of ZntA-expressing strain in the presence of different 
metal salts. The ATPase activity assay confirmed the earlier findings that ZntA is active in 
the presence of Zn2+, Cd2+ and Pb2+. In the ATP phosphorylation assay also Cu2+ induced a 
marked phosphorylation of the protein, whereas Ni2+ had a small effect. These findings 
have been confirmed by Hou et Mitra, 2003. However, the current evidence does not tell, 
whether these two cations are really transported by ZntA. Clearly, an actual transport 
activity assay is needed to answer this question.  
 
5.2 N-terminal metal-binding site CxxC 
 
Mutations in the N-terminal metal-binding site have little effect on ATP phosphorylation. 
Instead, Pi phosphorylation is clearly affected. In the presence of zinc the mutants reveal 
their complex phenotype that is difficult to explain fully at this stage. It can be concluded 
that the mutations affect specifically the E2 state. The N-terminus has been previously 
reported to interact with the loop containing N and P domains (Tsivkovskii et al., 2001). 
Also, mutations at the metal-binding site have been reported to affect the 
dephosphorylation step, which occurs in the E2 state (Mandal & Argüello, 2003). One 
possibility is that the N-terminus interacts with the P domain in a way that prevents the 
function of the A domain. The binding of a metal ion to the N-terminus would break down 
the interaction, thus enhancing the rate of ZntA. The results do not support the N-terminus 
to enhance the activity in low metal concentrations as suggested in Voskoboinik et al., 
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2001. Instead, it seems that the N-terminus functions to inhibit ATPase activity at low 
metal concentrations. 
 
5.3 CPx motif – The translocation site 
 
The SPS mutant undergoes phosphorylation in the presence of ATP and Pi, suggesting that 
it might have low residual ATPase activity. Also, it reacts with zinc at submicromolar 
concentrations, in spite of the fact that both metal liganding cysteines have been replaced 
with serines. Phosphorylation is completely abolished if the CPC sequence is replaced with 
APA. These results imply that there are other liganding residues in the intramembraneous 
metal-binding site. The N-terminal metal-binding site of ZntA has been shown to consist of 
an aspartate residue in addition to two cysteines (Banci et al., 2002). An aspartate is also 
found in the seventh TM-helix that is conserved only among Zn2+-ATPases (Argüello, 
2003). The role of the aspartate remains to be characterized, but these results provide the 
first experimental evidence for the idea that the intramembraneous metal-binding site is not 
formed solely by the CPx motif.   
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Conclusions 
 
The important general finding of this study is that all Wilson disease mutation analogs 
characterized resulted in a clear biochemical effect on the bacterial counterpart, ZntA. This 
suggests that the P1B-ATPases share a common functional mechanism despite the structural 
differences.  
 
The modelling of N domain suggests that the core is conserved throughout the members of 
the P-type ATPase superfamily. It is demonstrated, that a model can be constructed 
bringing all the putative ATP-binding-site-forming residues (H475P and G503xGxxG/A 
motif, C518 and E470) together without disturbing the common core structure of the N 
domain. 
 
Two new conformational mutants were discovered in this work. G444V and P634L are 
both Wilson disease mutant analogs. On the basis of their ATP and Pi phosphorylation 
characteristics, they favor E2 and E1 states respectively. G444V results in a phenotype, that 
responds normally to the binding of substrate cations by converting from the E2 to E1 state, 
but fails to do so in the presence of ATP. The mutation P634L leads to the accumulation of 
the E1~P state, which dephosphorylates slowly in normal conditions, but very fast in the 
presence of excess ADP. 
 
The experimental evidence from molecular modelling and mutagenesis suggests the two 
conserved sequence motifs found in the N domain of P1B-ATPases, the H475P and the 
G503xGxxA to participate in the ATP binding. Mutations in these motifs dramatically 
reduce ATP phosphorylation, which is relieved at higher ATP concentrations, suggesting an 
ATP-binding defect. Mutations in the glycine motif also partially impaire the ATP-
dependent E2-E1 state transition, while no such effect is observed in H475 mutants.  
Instead, mutations of the His475 result in a general Pi phosphorylation defect, which can be 
explained if the residue makes contact with the A domain. This is supported by the 
molecular model of the N domain of ZntA. 
 
Mutations in the N-terminal metal-binding site C59xxC do not change the metal affinity of 
the ATPase. Hence, the domain is not taking part in metal translocation. Instead, mutational 
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effects are seen in Pi phosphorylation, indicating a regulatory role for the CxxC metal-
binding site. It is suggested to be inhibitory in nature, preventing the futile ATPase activity 
in the absence of substrate cations. 
Replacing the intramembraneous C392PC site with APA results in an inactive ATPase, 
whereas substituting it with SPS retains a residual activity. This finding supports the recent 
suggestion that the intramembraneous metal-binding site is not formed solely by the CPx 
motif, but also other metal ligands exist. 
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